false--06-300001831096Q320230001831096us-gaap:RestrictedStockMembersrt:MaximumMember2022-07-012023-03-310001831096us-gaap:FairValueInputsLevel1Membergeg:ConsolidatedFundMember2022-06-300001831096geg:GreatElmCapitalCorpMember2022-12-012022-12-310001831096geg:PromissoryNoteMember2022-07-012023-03-310001831096us-gaap:NoncontrollingInterestMember2021-06-3000018310962021-12-310001831096us-gaap:FairValueInputsLevel2Membergeg:ConsolidatedFundMember2022-06-300001831096geg:RelatedPartyBorrowingsSubsidiariesMember2023-03-310001831096geg:PromissoryNoteMember2022-12-300001831096us-gaap:ParentMember2023-03-310001831096us-gaap:RestrictedStockMember2023-03-310001831096geg:EmployeesMembergeg:MpIiRestrictedMember2023-01-012023-03-310001831096srt:MinimumMember2022-07-012023-03-310001831096us-gaap:RestrictedStockMembersrt:MinimumMember2022-07-012023-03-310001831096geg:EmployeesMembergeg:GECCCommonSharesMember2022-07-012023-03-310001831096geg:GreatElmHealthcareLLCMember2022-06-300001831096geg:MonomoyPropertiesReitLlcMemberus-gaap:MeasurementInputPriceVolatilityMember2023-03-310001831096geg:GegglNotesMember2022-07-012023-03-310001831096geg:ForestPreferredStockClassifiedAsLiabilityMembergeg:ForestInvestmentsIncMember2020-12-290001831096us-gaap:CommonStockMember2022-01-012022-03-310001831096geg:GegglNotesMembersrt:MinimumMember2022-06-092022-06-090001831096us-gaap:CommonStockMember2021-07-012021-09-300001831096geg:MonomoyPropertiesReitLlcMemberus-gaap:MeasurementInputPriceVolatilityMember2022-06-300001831096us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001831096us-gaap:ParentMember2022-10-012022-12-310001831096geg:DurableMedicalEquipmentRentalIncomeMember2021-07-012022-03-310001831096us-gaap:ParentMember2023-01-012023-03-310001831096us-gaap:CommonStockMember2022-03-310001831096us-gaap:FairValueInputsLevel2Member2023-03-310001831096geg:MonomoyPropertiesReitLlcMember2022-05-040001831096geg:ForestPreferredStockMember2020-12-292020-12-290001831096us-gaap:CommonStockMember2022-10-012022-12-310001831096us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001831096us-gaap:FairValueInputsLevel12And3Member2022-06-300001831096geg:TaxPeriodTwoMember2022-06-300001831096us-gaap:NoncontrollingInterestMember2021-10-012021-12-3100018310962021-07-012022-03-310001831096geg:StockPurchaseAgreementMember2022-12-302022-12-300001831096us-gaap:ConvertibleDebtMember2022-01-012022-03-3100018310962022-06-300001831096geg:GreatElmCapitalCorpMember2023-02-012023-02-280001831096us-gaap:RetainedEarningsMember2022-10-012022-12-310001831096us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001831096geg:ForestInvestmentIncMember2023-03-310001831096us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2022-06-300001831096geg:ForestPreferredStockClassifiedAsLiabilityMembergeg:ForestInvestmentsIncMember2023-01-012023-03-3100018310962023-03-310001831096geg:GreatElmGroupIncMembergeg:GegglNotesMembergeg:SubsidiariesOtherOutstandingBorrowingsMember2022-06-300001831096us-gaap:DeferredCompensationShareBasedPaymentsMember2023-03-310001831096geg:GreatElmSPACOpportunitiesFundLLCMember2022-07-012022-07-310001831096us-gaap:ParentMember2022-12-310001831096geg:ForestPreferredStockClassifiedAsLiabilityMembergeg:ForestInvestmentsIncMember2022-01-012022-03-310001831096geg:ServiceBasedRestrictedStockAwardsMember2022-07-012023-03-310001831096srt:MaximumMembergeg:TaxPeriodOneMember2021-07-012022-06-300001831096geg:MonomoyPropertiesReitLlcMemberus-gaap:MeasurementInputDiscountRateMember2023-03-310001831096geg:EmployeesMembergeg:GECCCommonSharesMember2023-01-012023-03-3100018310962021-10-012021-12-310001831096us-gaap:RetainedEarningsMember2022-03-310001831096geg:SeriesA2PreferredInterestsMember2022-12-290001831096geg:ForestInvestmentsIncMember2022-10-012022-12-310001831096us-gaap:RetainedEarningsMember2021-12-310001831096us-gaap:ParentMember2022-09-300001831096geg:GegglNotesMember2022-06-090001831096us-gaap:CommonStockMember2021-09-300001831096us-gaap:ParentMember2021-12-310001831096us-gaap:StockCompensationPlanMember2021-07-012022-03-310001831096us-gaap:ManagementServiceBaseMember2021-07-012022-03-310001831096us-gaap:RestrictedStockMember2023-01-012023-03-310001831096us-gaap:CommonStockMember2023-01-012023-03-310001831096us-gaap:RetainedEarningsMember2022-12-310001831096us-gaap:NoncontrollingInterestMember2021-07-012021-09-300001831096us-gaap:RestrictedStockUnitsRSUMember2022-07-012023-03-310001831096us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001831096geg:ManagedInvestmentProductsMember2023-03-310001831096geg:ManagedInvestmentProductsMember2023-01-012023-03-310001831096us-gaap:ParentMember2021-07-012021-09-300001831096us-gaap:ParentMember2021-10-012021-12-310001831096us-gaap:FairValueInputsLevel1Member2022-06-300001831096geg:ImperialCapitalAssetManagementLLCMember2023-01-032023-01-030001831096us-gaap:ConvertibleDebtSecuritiesMember2021-07-012022-03-310001831096us-gaap:AdditionalPaidInCapitalMember2021-09-300001831096us-gaap:AdditionalPaidInCapitalMember2022-06-300001831096us-gaap:CommonStockMember2022-07-012023-03-310001831096geg:PromissoryNoteMember2023-01-012023-03-310001831096geg:ManagedInvestmentProductsMember2022-07-012023-03-310001831096us-gaap:RetainedEarningsMember2022-09-300001831096geg:SubsidiariesOtherOutstandingBorrowingsMember2023-03-310001831096geg:ManagedInvestmentProductsMember2022-01-012022-03-310001831096us-gaap:AdditionalPaidInCapitalMember2021-10-012021-12-310001831096us-gaap:AdditionalPaidInCapitalMember2022-10-012022-12-310001831096us-gaap:NoncontrollingInterestMember2022-06-300001831096us-gaap:CommonStockMember2022-06-300001831096geg:GreatElmGroupIncMembergeg:GegglNotesMembergeg:SubsidiariesOtherOutstandingBorrowingsMember2023-03-310001831096geg:ForestInvestmentsIncMember2022-07-012022-12-310001831096geg:EmployeesMembergeg:MpIiRestrictedMember2022-07-012023-03-310001831096geg:ForestInvestmentsIncMember2022-07-012023-03-310001831096geg:ForestPreferredStockMember2020-12-290001831096geg:TaxPeriodOneMember2022-06-300001831096geg:MonomoyPropertiesReitLlcMember2022-06-300001831096us-gaap:ManagementServiceBaseMember2023-01-012023-03-310001831096geg:GreatElmSPACOpportunitiesFundLLCMember2022-06-300001831096us-gaap:RetainedEarningsMember2021-10-012021-12-310001831096geg:GreatElmHealthcareLLCMember2021-07-012022-03-310001831096us-gaap:FairValueInputsLevel2Member2022-06-300001831096geg:SharedPersonnelAndReimbursementAgreementMembergeg:InvestmentManagementExpensesMembergeg:JasonWReeseMember2021-07-012022-03-310001831096geg:GreatElmCapitalGPLLCMember2022-01-012022-03-3100018310962023-01-010001831096geg:PromissoryNoteMember2022-12-292022-12-290001831096us-gaap:AdditionalPaidInCapitalMember2022-09-300001831096us-gaap:EmployeeStockOptionMember2022-07-012023-03-310001831096geg:DurableMedicalEquipmentRentalIncomeMember2022-07-012023-03-310001831096geg:GECCCommonSharesMember2022-07-012023-03-310001831096geg:SubsidiariesOtherOutstandingBorrowingsMember2022-06-300001831096geg:PromissoryNoteMembergeg:StockPurchaseAgreementMember2022-12-300001831096us-gaap:NoncontrollingInterestMember2022-09-300001831096srt:MaximumMember2022-07-012023-03-310001831096geg:ForestPreferredStockClassifiedAsLiabilityMembergeg:ForestInvestmentsIncMember2022-07-012023-03-310001831096geg:GreatElmCapitalCorpMember2023-03-310001831096geg:StockPurchaseAgreementMember2022-12-300001831096geg:SharedPersonnelAndReimbursementAgreementMembergeg:InvestmentManagementExpensesMembergeg:JasonWReeseMember2023-01-012023-03-310001831096geg:GreatElmCapitalManagementIncMembergeg:SellerNoteMembergeg:RelatedPartyBorrowingsSubsidiariesMember2022-06-300001831096us-gaap:ManagementServiceBaseMember2022-01-012022-03-310001831096geg:ManagedInvestmentProductsMember2022-06-300001831096us-gaap:ConvertibleDebtMember2023-03-310001831096us-gaap:ParentMember2022-01-012022-03-310001831096us-gaap:CommonStockMember2022-09-300001831096us-gaap:EmployeeStockOptionMember2022-01-012022-03-310001831096geg:AdministrationAndServiceFeesMember2021-07-012022-03-310001831096geg:SharedPersonnelAndReimbursementAgreementMembergeg:InvestmentManagementExpensesMembergeg:JasonWReeseMember2022-01-012022-03-310001831096us-gaap:AdditionalPaidInCapitalMember2022-12-310001831096us-gaap:AdditionalPaidInCapitalMember2021-12-310001831096us-gaap:RetainedEarningsMember2021-09-300001831096geg:GegglNotesMemberus-gaap:OverAllotmentOptionMember2022-06-090001831096us-gaap:CommonStockMember2023-03-310001831096geg:ForestInvestmentsIncMember2022-07-012023-03-310001831096geg:ConsolidatedFundMember2021-07-012022-03-310001831096geg:GreatElmCapitalCorpMember2022-08-012022-08-310001831096geg:GreatElmCapitalManagementIncMembergeg:SellerNoteMembergeg:InvestmentManagementAgreementAndCertainOtherAssetsForMonomoyPropertiesReitLLCMember2022-05-040001831096geg:RelatedPartyBorrowingsSubsidiariesMember2022-06-300001831096us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2023-03-310001831096us-gaap:RetainedEarningsMember2021-06-300001831096us-gaap:CommonStockMember2022-12-3100018310962022-10-012022-12-310001831096geg:AdministrationAndServiceFeesMember2022-07-012023-03-310001831096us-gaap:StockCompensationPlanMember2022-07-012023-03-310001831096us-gaap:NoncontrollingInterestMember2022-03-310001831096geg:ImperialCapitalAssetManagementLLCMember2021-10-012021-10-310001831096geg:ConsolidatedFundMember2022-01-012022-03-310001831096geg:SalesAndServicesOfDurableMedicalEquipmentMember2022-01-012022-03-310001831096geg:AdministrationAndServiceFeesMember2022-01-012022-03-3100018310962022-07-012023-03-310001831096us-gaap:NoncontrollingInterestMember2022-12-310001831096us-gaap:ParentMember2022-03-310001831096us-gaap:RetainedEarningsMember2022-01-012022-03-310001831096geg:PromissoryNoteMember2022-12-310001831096us-gaap:CommonStockMember2021-10-012021-12-310001831096us-gaap:EmployeeStockOptionMember2021-07-012022-03-310001831096us-gaap:FairValueInputsLevel3Membergeg:ConsolidatedFundMember2022-06-3000018310962021-09-300001831096us-gaap:RestrictedStockMember2022-07-012023-03-310001831096geg:GreatElmHealthcareLLCMember2022-07-012023-03-310001831096us-gaap:ConvertibleDebtMember2021-07-012022-06-300001831096us-gaap:CommonStockMember2022-07-012022-09-300001831096us-gaap:ParentMember2022-07-012022-09-300001831096us-gaap:ConvertibleDebtMember2023-01-012023-03-310001831096us-gaap:FairValueInputsLevel3Member2023-03-310001831096geg:AdministrationAndServiceFeesMember2023-01-012023-03-310001831096us-gaap:DeferredCompensationShareBasedPaymentsMember2020-12-012020-12-3100018310962022-12-310001831096geg:SevenPointTwoFivePercentNotesDueTwoThousandTwentySevenMember2022-07-012023-03-3100018310962021-07-012022-06-300001831096us-gaap:ConvertibleDebtSecuritiesMember2022-07-012023-03-310001831096us-gaap:FairValueInputsLevel3Member2022-06-300001831096us-gaap:RetainedEarningsMember2022-06-3000018310962022-07-012022-09-300001831096us-gaap:RetainedEarningsMember2023-01-012023-03-310001831096geg:MonomoyPropertiesReitLlcMemberus-gaap:MeasurementInputDiscountRateMember2022-06-300001831096geg:PropertyManagementFeesMember2022-07-012023-03-310001831096geg:TaxPeriodFourMember2022-07-012023-03-310001831096geg:SeriesA1PreferredInterestsMember2022-12-290001831096geg:ForestInvestmentsIncMember2022-06-300001831096us-gaap:ManagementServiceBaseMember2022-07-012023-03-3100018310962023-01-012023-03-310001831096geg:GeccGpCorpMember2023-03-310001831096us-gaap:RetainedEarningsMember2023-03-310001831096us-gaap:ConvertibleDebtMember2021-07-012022-03-310001831096geg:ForestInvestmentsIncMember2022-01-012022-03-310001831096geg:ConsolidatedFundMemberus-gaap:FairValueInputsLevel12And3Member2022-06-300001831096us-gaap:RestrictedStockMember2022-06-300001831096us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001831096geg:QuiptHomeMedicalCorporationMembergeg:QhmHoldingsIncorporationMembergeg:GreatElmHealthcareLLCMember2023-01-032023-01-030001831096us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001831096geg:ForestPreferredStockClassifiedAsLiabilityMembergeg:ForestInvestmentsIncMember2020-12-292020-12-290001831096us-gaap:ParentMember2021-09-300001831096geg:ConsolidatedFundMember2022-06-3000018310962021-07-012021-09-300001831096us-gaap:FairValueInputsLevel1Member2023-03-310001831096geg:GegglNotesMember2022-06-092022-06-090001831096us-gaap:ConvertibleDebtMember2022-07-012023-03-310001831096us-gaap:ConvertibleDebtMember2022-06-300001831096geg:SalesAndServicesOfDurableMedicalEquipmentMember2021-07-012022-03-310001831096us-gaap:RetainedEarningsMember2022-07-012022-09-300001831096us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001831096us-gaap:CommonStockMember2021-12-3100018310962022-09-3000018310962022-03-310001831096geg:DurableMedicalEquipmentRentalIncomeMember2022-01-012022-03-310001831096us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001831096geg:TaxPeriodThreeMember2022-06-300001831096us-gaap:ParentMember2021-06-300001831096geg:GreatElmHealthcareLLCMember2022-01-012022-03-310001831096geg:SharedPersonnelAndReimbursementAgreementMembergeg:InvestmentManagementExpensesMembergeg:JasonWReeseMember2022-07-012023-03-310001831096geg:MpIiRestrictedMember2022-07-012023-03-310001831096us-gaap:AdditionalPaidInCapitalMember2023-03-310001831096geg:RestrictedStockAwardsAndStockOptionsMember2023-03-310001831096us-gaap:AdditionalPaidInCapitalMember2022-03-310001831096us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001831096geg:TaxPeriodFourMember2022-06-300001831096us-gaap:NoncontrollingInterestMember2021-09-300001831096us-gaap:RetainedEarningsMember2021-07-012021-09-300001831096us-gaap:NoncontrollingInterestMember2021-12-310001831096geg:GreatElmHealthcareLLCMembergeg:CorbelCapitalPartnersSBICLPMember2023-03-310001831096us-gaap:ParentMember2022-06-300001831096geg:SalesAndServicesOfDurableMedicalEquipmentMember2022-07-012023-03-3100018310962021-06-300001831096geg:ForestInvestmentsIncMembergeg:PromissoryNoteMembergeg:StockPurchaseAgreementMember2022-12-300001831096geg:ForestInvestmentsIncMember2023-01-012023-03-3100018310962023-01-032023-01-0300018310962022-01-012022-03-310001831096us-gaap:AdditionalPaidInCapitalMember2021-06-300001831096geg:PromissoryNoteMembergeg:StockPurchaseAgreementMember2022-12-302022-12-300001831096geg:ConsolidatedFundMember2022-07-012023-03-3100018310962023-04-270001831096geg:ForestInvestmentsIncMember2021-07-012022-03-310001831096us-gaap:FairValueInputsLevel12And3Member2023-03-310001831096geg:ValleyHealthcareGroupLLCMembergeg:GreatElmHealthcareLLCMember2023-03-310001831096us-gaap:CommonStockMember2021-06-300001831096geg:GreatElmCapitalGPLLCMember2021-07-012022-03-310001831096srt:MinimumMembergeg:TaxPeriodOneMember2021-07-012022-06-300001831096geg:InflationReductionActMember2022-08-162022-08-160001831096geg:MpIiRestrictedMember2023-01-012023-03-3100018310962023-01-030001831096geg:GreatElmCapitalManagementIncMembergeg:SellerNoteMembergeg:InvestmentManagementAgreementAndCertainOtherAssetsForMonomoyPropertiesReitLLCMember2022-05-042022-05-040001831096geg:MonomoyPropertiesReitLlcMember2023-03-310001831096geg:ManagedInvestmentProductsMember2021-07-012022-03-310001831096geg:GECCAndOtherPrivateFundsManagedByGECMMember2022-07-012023-03-310001831096geg:QuiptHomeMedicalCorporationMembergeg:QhmHoldingsIncorporationMembergeg:GreatElmHealthcareLLCMember2023-01-030001831096us-gaap:NoncontrollingInterestMember2022-10-012022-12-310001831096geg:PromissoryNoteMembergeg:ForestInvestmentIncMembergeg:StockPurchaseAgreementMember2022-12-300001831096geg:PropertyManagementFeesMember2023-01-012023-03-310001831096geg:PromissoryNoteMember2022-12-290001831096geg:ForestInvestmentsIncMember2023-01-172023-01-170001831096geg:ForestPreferredStockClassifiedAsLiabilityMembergeg:ForestInvestmentsIncMember2021-07-012022-03-31geg:Projectxbrli:purexbrli:sharesiso4217:USDxbrli:sharesiso4217:USDgeg:Segment

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2023

 

or

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

 

Commission File Number: 001-39832

 

 

Great Elm Group, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

85-3622015

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

800 South Street, Suite 230, Waltham MA

02453

(Address of principal executive offices)

(Zip Code)

(617) 375-3006

(Registrant’s telephone number, including area code)

 

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

GEG

The Nasdaq Stock Market LLC

(Nasdaq Global Select Market)

7.25% Notes due 2027

GEGGL

The Nasdaq Stock Market LLC

(Nasdaq Global Select Market)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 

As of April 27, 2023, there were 30,643,918 shares of the registrant’s common stock outstanding.

 


 

Table of Contents

 

PART I. FINANCIAL INFORMATION

 

 

 

 

Item 1.

 

Financial Statements

3

 

 

Unaudited Condensed Consolidated Balance Sheets as of March 31, 2023 and June 30, 2022

3

 

 

Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2023 and 2022

4

 

 

Unaudited Condensed Consolidated Statement of Stockholders’ Equity and Contingently Redeemable Non-Controlling Interest for the three months ended March 31, 2023, December 31, 2022, and September 30, 2022

5

 

 

Unaudited Condensed Consolidated Statement of Stockholders’ Equity and Contingently Redeemable Non-Controlling Interest for the three months ended March 31, 2022, December 31, 2021, and September 30, 2021

6

 

 

Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2023 and 2022

7

 

 

Unaudited Notes to Condensed Consolidated Financial Statements

9

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

28

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

32

Item 4.

 

Controls and Procedures

32

 

 

 

 

PART II. OTHER INFORMATION

32

 

 

 

 

Item 1.

 

Legal Proceedings

32

Item 1A.

 

Risk Factors

33

Item 6.

 

Exhibits

33

 

 

 

 

SIGNATURES

34

 

Unless the context otherwise requires, “we,” “us,” “our,” “GEG,” the “Company” and terms of similar import refer to Great Elm Group, Inc. and/or its subsidiaries. Our corporate website address is www.greatelmgroup.com. The information contained in, or accessible through, our corporate website does not constitute part of this report.

1


Cautionary Statement Regarding Forward-Looking Information

This report and certain information incorporated herein by reference, contain forward‑looking statements under the Private Securities Litigation Reform Act of 1995. Such statements often include words such as “may,” “will,” “should,” “believe,” “expect,” “seek,” “anticipate,” “intend,” “estimate,” “plan,” “target,” “project,” “forecast,” “envision” and other similar phrases. Although we believe the assumptions and expectations reflected in these forward‑looking statements are reasonable, these assumptions and expectations may not prove to be correct and we may not achieve the financial results or benefits anticipated. These forward‑looking statements are not guarantees of actual results. Our actual results may differ materially from those suggested in the forward‑looking statements. These forward‑looking statements involve a number of risks and uncertainties, some of which are beyond our control, including, without limitation:

the ability of Great Elm Capital Management, Inc. to profitably manage Great Elm Capital Corp. (NASDAQ: GECC), a business development company that we manage through our investment management business, and Monomoy Properties UpREIT, LLC (Monomoy UpREIT), the operating subsidiary of a private real estate investment trust with a portfolio of diversified net leased industrial assets that we manage through our investment management business;
the dividend rate that GECC and Monomoy UpREIT will pay;
the results of our investment management business;
our ability to sell the real estate properties we develop at a profit;
our ability to raise capital to fund our business plan;
our ability to make acquisitions and manage any businesses we may acquire;
conditions in the equity capital markets and debt capital markets as well as the economy generally, including rising interest rates and inflationary pressures;
our ability to maintain the security of electronic and other confidential information;
serious disruptions and catastrophic events, including the impact of the novel coronavirus (COVID‑19) pandemic or similar public health emergencies on the global economy;
the impact of on-going or worsening supply chain challenges;
competition, mostly from larger, well-financed organizations (both domestic and foreign), including operating companies, global asset managers, investment banks, commercial banks, and private equity funds;
outcomes of litigation and proceedings and the availability of insurance, indemnification and other third-party coverage of any losses suffered in connection therewith;
maintaining our contractual arrangements and relationships with third parties;
our ability to attract, assimilate, develop and retain key personnel;
compliance with laws, regulations and orders;
changes in laws and regulations governing our operations; and
other factors described in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 under “Risk Factors” or as set forth from time to time in our Securities and Exchange Commission filings.

These forward‑looking statements speak only as of the time of filing of this report and we do not undertake to update or revise them as more information becomes available. You are cautioned not to place undue reliance on these forward‑looking statements. We do not undertake any obligation to release publicly any revisions to these forward‑looking statements to reflect future events or circumstances or to reflect the occurrence of unanticipated events.

2


PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

Great Elm Group, Inc.

Condensed Consolidated Balance Sheets (Unaudited)

Dollar amounts in thousands (except per share data)

ASSETS

 

March 31, 2023

 

 

June 30, 2022

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

84,118

 

 

$

22,281

 

Receivables from managed funds

 

 

2,421

 

 

 

2,445

 

Investments, at fair value (cost $41,079 and $68,766, respectively)

 

 

35,104

 

 

 

48,042

 

Prepaid and other current assets

 

 

946

 

 

 

665

 

Assets of Consolidated Fund:

 

 

 

 

 

 

Investments, at fair value (cost $2,432)

 

 

-

 

 

 

1,797

 

Prepaid expenses

 

 

-

 

 

 

746

 

Real estate under development

 

 

1,683

 

 

 

-

 

Current assets held for sale

 

 

-

 

 

 

8,464

 

Total current assets

 

 

124,272

 

 

 

84,440

 

Identifiable intangible assets, net

 

 

12,391

 

 

 

13,250

 

Right of use assets

 

 

582

 

 

 

733

 

Other assets

 

 

137

 

 

 

103

 

Non-current assets held for sale

 

 

-

 

 

 

69,561

 

Total assets

 

$

137,382

 

 

$

168,087

 

LIABILITIES, NON-CONTROLLING INTEREST AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

307

 

 

$

8

 

Accrued expenses and other liabilities

 

 

4,122

 

 

 

3,845

 

Current portion of related party payables

 

 

855

 

 

 

486

 

Current portion of lease liabilities

 

 

347

 

 

 

341

 

Liabilities of Consolidated Fund - accrued expenses and other

 

 

-

 

 

 

11

 

Current liabilities held for sale

 

 

-

 

 

 

15,003

 

Total current liabilities

 

 

5,631

 

 

 

19,694

 

Lease liabilities, net of current portion

 

 

245

 

 

 

472

 

Long term debt (face value $26,945)

 

 

25,737

 

 

 

25,532

 

Related party payables

 

 

445

 

 

 

1,120

 

Related party notes payable, net of current portion

 

 

-

 

 

 

6,270

 

Convertible notes (face value $36,987 and $36,085, including $15,019 and $15,133 held by related parties, respectively)

 

 

36,176

 

 

 

35,187

 

Redeemable preferred stock of subsidiaries (held by related parties, face value $35,010)

 

 

-

 

 

 

34,099

 

Other liabilities

 

 

691

 

 

 

908

 

Non-current liabilities held for sale

 

 

-

 

 

 

2,551

 

Total liabilities

 

 

68,925

 

 

 

125,833

 

Commitments and contingencies (Note 14)

 

 

 

 

 

 

Contingently redeemable non-controlling interest

 

 

-

 

 

 

2,225

 

Stockholders' equity

 

 

 

 

 

 

Preferred stock, $0.001 par value; 5,000,000 authorized and zero outstanding

 

 

-

 

 

 

-

 

Common stock, $0.001 par value; 350,000,000 shares authorized and 30,598,911 shares issued and 29,146,053 outstanding at March 31, 2023; and 28,932,444 shares issued and 28,507,490 outstanding at June 30, 2022

 

 

29

 

 

 

29

 

Additional paid-in-capital

 

 

3,314,737

 

 

 

3,312,763

 

Accumulated deficit

 

 

(3,246,309

)

 

 

(3,279,296

)

Total Great Elm Group, Inc. stockholders' equity

 

 

68,457

 

 

 

33,496

 

Non-controlling interest

 

 

-

 

 

 

6,533

 

Total stockholders' equity

 

 

68,457

 

 

 

40,029

 

Total liabilities, non-controlling interest and stockholders' equity

 

$

137,382

 

 

$

168,087

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

3


Great Elm Group, Inc.

Condensed Consolidated Statements of Operations (Unaudited)

Amounts in thousands (except per share data)

 

 

For the three months ended March 31,

 

 

For the nine months ended March 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Revenues

 

$

1,898

 

 

$

988

 

 

$

5,637

 

 

$

2,992

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Investment management expenses

 

 

2,593

 

 

 

1,592

 

 

 

6,893

 

 

 

4,748

 

Depreciation and amortization

 

 

281

 

 

 

89

 

 

 

870

 

 

 

307

 

Selling, general and administrative

 

 

1,893

 

 

 

1,582

 

 

 

5,441

 

 

 

4,620

 

Expenses of Consolidated Fund

 

 

-

 

 

 

42

 

 

 

46

 

 

 

139

 

Total operating costs and expenses

 

 

4,767

 

 

 

3,305

 

 

 

13,250

 

 

 

9,814

 

Operating loss

 

 

(2,869

)

 

 

(2,317

)

 

 

(7,613

)

 

 

(6,822

)

Dividends and interest income

 

 

1,520

 

 

 

642

 

 

 

4,432

 

 

 

1,939

 

Net realized and unrealized gain (loss) on investments

 

 

1,989

 

 

 

(3,220

)

 

 

17,434

 

 

 

(5,055

)

Net realized and unrealized loss on investments of Consolidated Fund

 

-

 

 

 

(284

)

 

 

(16

)

 

 

(279

)

Gain on sale of controlling interest in subsidiary

 

 

-

 

 

 

-

 

 

 

10,524

 

 

 

-

 

Interest expense

 

 

(1,095

)

 

 

(1,286

)

 

 

(5,024

)

 

 

(3,872

)

(Loss) income before income taxes from continuing operations

 

 

(455

)

 

 

(6,465

)

 

 

19,737

 

 

 

(14,089

)

Income tax (expense) benefit

 

 

-

 

 

 

(2

)

 

 

(2

)

 

 

83

 

Net (loss) income from continuing operations

 

 

(455

)

 

 

(6,467

)

 

 

19,735

 

 

 

(14,006

)

Discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

Net income from discontinued operations

 

 

12,203

 

 

 

332

 

 

 

13,202

 

 

 

3,818

 

Net income (loss)

 

$

11,748

 

 

$

(6,135

)

 

$

32,937

 

 

$

(10,188

)

Less: net income (loss) attributable to non-controlling interest, continuing operations

 

 

-

 

 

 

1,146

 

 

 

(1,554

)

 

 

913

 

Less: net (loss) income attributable to non-controlling interest, discontinued operations

 

 

-

 

 

 

(1,372

)

 

 

1,504

 

 

 

(754

)

Net income (loss) attributable to Great Elm Group, Inc.

 

$

11,748

 

 

$

(5,909

)

 

$

32,987

 

 

$

(10,347

)

Basic income (loss) per share from:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(0.02

)

 

$

(0.28

)

 

$

0.74

 

 

$

(0.55

)

Discontinued operations

 

 

0.42

 

 

 

0.06

 

 

 

0.41

 

 

 

0.17

 

Basic net income (loss) per share

 

$

0.40

 

 

$

(0.22

)

 

$

1.15

 

 

$

(0.38

)

Diluted income (loss) per share from:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(0.02

)

 

$

(0.28

)

 

$

0.56

 

 

$

(0.55

)

Discontinued operations

 

 

0.42

 

 

 

0.06

 

 

 

0.29

 

 

 

0.17

 

Diluted net income (loss) per share

 

$

0.40

 

 

$

(0.22

)

 

$

0.85

 

 

$

(0.38

)

Weighted average shares outstanding

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

28,997

 

 

 

26,842

 

 

 

28,779

 

 

 

26,963

 

Diluted

 

 

28,997

 

 

 

26,842

 

 

 

40,673

 

 

 

26,963

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4


Great Elm Group, Inc.

Condensed Consolidated Statements of Stockholders’ Equity and Contingently Redeemable Non-controlling Interest (Unaudited)

Amounts in thousands

 

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Accumulated

 

 

 

Total Great Elm Group, Inc. Stockholders'

 

 

Non-
controlling

 

 

Total Stockholders'

 

 

 

Contingently Redeemable Non-controlling

 

 

Shares

 

Amount

 

Capital

 

Deficit

 

 

 

Equity

 

 

Interest

 

 

Equity

 

 

 

Interest

 

BALANCE, June 30, 2022

 

 

28,507

 

 

$

29

 

 

$

3,312,763

 

 

$

(3,279,296

)

 

 

$

33,496

 

 

$

6,533

 

 

$

40,029

 

 

 

$

2,225

 

Net (loss) income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(8,291

)

 

 

 

(8,291

)

 

 

(910

)

 

 

(9,201

)

 

 

 

662

 

Distributions to non-controlling interests in Consolidated Fund

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

(634

)

 

 

(634

)

 

 

 

-

 

Issuance of common stock related to vesting of restricted stock

 

 

267

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

834

 

 

 

-

 

 

 

 

834

 

 

 

-

 

 

 

834

 

 

 

 

-

 

BALANCE, September 30, 2022

 

 

28,774

 

 

$

29

 

 

$

3,313,597

 

 

$

(3,287,587

)

 

 

$

26,039

 

 

$

4,989

 

 

$

31,028

 

 

 

$

2,887

 

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

29,530

 

 

 

 

29,530

 

 

 

108

 

 

 

29,638

 

 

 

 

90

 

Redemption of non-controlling interests upon sale of controlling interest in subsidiary

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

(2,120

)

 

 

(2,120

)

 

 

 

-

 

Issuance of common stock related to vesting of restricted stock

 

 

202

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

576

 

 

 

-

 

 

 

 

576

 

 

 

-

 

 

 

576

 

 

 

 

-

 

BALANCE, December 31, 2022

 

 

28,976

 

 

$

29

 

 

$

3,314,173

 

 

$

(3,258,057

)

 

 

$

56,145

 

 

$

2,977

 

 

$

59,122

 

 

 

$

2,977

 

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

11,748

 

 

 

 

11,748

 

 

 

-

 

 

 

11,748

 

 

 

 

-

 

Redemption of non-controlling interests upon sale of subsidiaries

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

(2,977

)

 

 

(2,977

)

 

 

 

(2,977

)

Issuance of common stock related to vesting of restricted stock

 

 

170

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

564

 

 

 

-

 

 

 

 

564

 

 

 

-

 

 

 

564

 

 

 

 

-

 

BALANCE, March 31, 2023

 

 

29,146

 

 

$

29

 

 

$

3,314,737

 

 

$

(3,246,309

)

 

 

$

68,457

 

 

$

-

 

 

$

68,457

 

 

 

$

-

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

5


Great Elm Group, Inc.

Condensed Consolidated Statements of Stockholders’ Equity and Contingently Redeemable Non-controlling Interest (Unaudited)

Amounts in thousands

 

 

 

Common Stock

 

 

Additional
Paid-in

 

 

Accumulated

 

 

 

Total Great Elm Group, Inc. Stockholders'

 

 

Non-
controlling

 

 

Total Stockholders'

 

 

 

Contingently Redeemable Non-controlling

 

 

Shares

 

Amount

 

Capital

 

Deficit

 

 

 

Equity

 

 

Interest

 

 

Equity

 

 

 

Interest

 

BALANCE, June 30, 2021

 

 

25,948

 

 

$

26

 

 

$

3,307,613

 

 

$

(3,264,403

)

 

 

$

43,236

 

 

$

9,549

 

 

$

52,785

 

 

 

$

2,639

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(200

)

 

 

 

(200

)

 

 

101

 

 

 

(99

)

 

 

 

205

 

Issuance of interests in Consolidated Fund, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

527

 

 

 

527

 

 

 

 

-

 

Issuance of common stock related to vesting of restricted stock

 

 

145

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

581

 

 

 

-

 

 

 

 

581

 

 

 

-

 

 

 

581

 

 

 

 

-

 

BALANCE, September 30, 2021

 

 

26,093

 

 

$

26

 

 

$

3,308,194

 

 

$

(3,264,603

)

 

 

$

43,617

 

 

$

10,177

 

 

$

53,794

 

 

 

$

2,844

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,238

)

 

 

 

(4,238

)

 

 

(24

)

 

 

(4,262

)

 

 

 

104

 

Redemption of interests in Consolidated Fund, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

(962

)

 

 

(962

)

 

 

 

-

 

Issuance of common stock related to vesting of restricted stock

 

 

722

 

 

1

 

 

 

-

 

 

 

-

 

 

 

 

1

 

 

 

-

 

 

 

1

 

 

 

 

-

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

1,131

 

 

 

-

 

 

 

 

1,131

 

 

 

-

 

 

 

1,131

 

 

 

 

-

 

BALANCE, December 31, 2021

 

 

26,815

 

 

$

27

 

 

$

3,309,325

 

 

$

(3,268,841

)

 

 

$

40,511

 

 

$

9,191

 

 

$

49,702

 

 

 

$

2,948

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,909

)

 

 

 

(5,909

)

 

 

460

 

 

 

(5,449

)

 

 

 

(686

)

Repurchase of interests in subsidiary

 

 

-

 

 

 

-

 

 

 

(129

)

 

 

-

 

 

 

 

(129

)

 

 

86

 

 

 

(43

)

 

 

 

-

 

Issuance of common stock related to vesting of restricted stock

 

 

148

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

-

 

Stock-based compensation

 

 

-

 

 

 

-

 

 

 

508

 

 

 

-

 

 

 

 

508

 

 

 

-

 

 

 

508

 

 

 

 

-

 

BALANCE, March 31, 2022

 

 

26,963

 

 

$

27

 

 

$

3,309,704

 

 

$

(3,274,750

)

 

 

$

34,981

 

 

$

9,737

 

 

$

44,718

 

 

 

$

2,262

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

6


Great Elm Group, Inc.

Condensed Consolidated Statements of Cash Flows (Unaudited)

Dollar amounts in thousands

 

 

 

For the nine months ended March 31,

 

 

 

2023

 

 

2022

 

Cash flows from operating activities:

 

 

 

 

 

 

Net income (loss) from continuing operations

 

$

19,735

 

 

$

(14,006

)

Adjustments to reconcile net income (loss) to net cash from operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

870

 

 

 

307

 

Stock-based compensation

 

 

1,974

 

 

 

2,220

 

Sales of investments by Consolidated Fund

 

 

1,558

 

 

 

24,523

 

Purchases of investments by Consolidated Fund

 

 

-

 

 

 

(11,687

)

Stock dividends received

 

 

-

 

 

 

(193

)

Unrealized loss on investments from Consolidated Fund

 

 

-

 

 

 

218

 

Realized loss on investments from Consolidated Fund

 

 

16

 

 

 

61

 

Unrealized (gain) loss on investments

 

 

(12,776

)

 

 

4,402

 

Realized (gain) loss on investments

 

 

(4,658

)

 

 

653

 

Gain on sale of controlling interest in subsidiary

 

 

(10,524

)

 

 

-

 

Non-cash interest and amortization of capitalized issuance costs

 

 

1,737

 

 

 

1,071

 

Deferred tax expense (benefit)

 

 

4

 

 

 

(89

)

Change in fair value of contingent consideration

 

 

180

 

 

 

-

 

Other non-cash expense, net

 

 

324

 

 

 

-

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Receivables from managed funds

 

 

(272

)

 

 

81

 

Prepaid assets, deposits, and other assets

 

 

778

 

 

 

385

 

Real estate under development

 

 

(1,600

)

 

 

-

 

Operating leases

 

 

(70

)

 

 

(16

)

Accounts payable, accrued expenses and other liabilities

 

 

(849

)

 

 

(1,115

)

Net cash (used in) provided by operating activities - continuing operations

 

 

(3,573

)

 

 

6,815

 

Net cash provided by operating activities - discontinued operations

 

 

766

 

 

 

8,593

 

Net cash (used in) provided by operating activities

 

 

(2,807

)

 

 

15,408

 

Cash flows from investing activities:

 

 

 

 

 

 

Proceeds from sale of controlling interest in subsidiary, net of cash sold

 

 

17,735

 

 

 

-

 

Purchases of investments

 

 

(3,105

)

 

 

(165

)

Sales of investments

 

 

26,527

 

 

 

187

 

Purchases of property and equipment

 

 

(37

)

 

 

(3

)

Net cash provided by investing activities - continuing operations

 

 

41,120

 

 

 

19

 

Net cash provided by (used in) investing activities - discontinued operations

 

 

67,230

 

 

 

(4,545

)

Net cash provided by (used in) investing activities

 

 

108,350

 

 

 

(4,526

)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

7


Great Elm Group, Inc.

Condensed Consolidated Statements of Cash Flows (Unaudited) (continued)

Dollar amounts in thousands

 

 

 

For the nine months ended March 31,

 

 

 

2023

 

 

2022

 

Cash flows from financing activities:

 

 

 

 

 

 

Principal payments on related party notes payable

 

 

(41,765

)

 

 

-

 

Repurchases of interests in subsidiary

 

 

-

 

 

 

(43

)

Distributions to non-controlling interests in Consolidated Fund

 

 

(634

)

 

 

(912

)

Due to broker of Consolidated Fund

 

 

-

 

 

 

(12,257

)

Capital contributions from non-controlling interests in Consolidated Fund

 

 

-

 

 

 

24

 

Net cash used in financing activities - continuing operations

 

 

(42,399

)

 

 

(13,188

)

Net cash (used in) provided by financing activities - discontinued operations

 

 

(5,221

)

 

 

670

 

Net cash used in financing activities

 

 

(47,620

)

 

 

(12,518

)

Net increase (decrease) in cash and cash equivalents, including cash and cash equivalents classified within current assets held for sale

 

 

57,923

 

 

 

(1,636

)

Less: net increase in cash and cash equivalents classified within current assets held for sale

 

 

(62,775

)

 

 

(4,718

)

Add: cash received from discontinued operations

 

 

66,689

 

 

 

4,329

 

Net increase (decrease) in cash and cash equivalents

 

 

61,837

 

 

 

(2,025

)

Cash and cash equivalents at beginning of period

 

 

22,281

 

 

 

18,745

 

Cash and cash equivalents at end of period

 

$

84,118

 

 

$

16,720

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

3,348

 

 

$

2,397

 

 

 

 

 

 

 

 

Non-cash investing and financing activities

 

 

 

 

 

 

Lease liabilities and right of use assets arising from operating leases

 

$

167

 

 

$

-

 

Partial settlement of Seller Note in exchange for GECC stock

 

$

2,609

 

 

$

-

 

Non-cash distributions received from Consolidated Fund

 

$

177

 

 

$

-

 

Equity consideration upon Sale of HC LLC

 

$

2,000

 

 

$

-

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

8


Great Elm Group, Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

March 31, 2023

1. Organization

Great Elm Group, Inc. (referred to as the Company or GEG) is an alternative asset management company incorporated in Delaware. The Company operates in one segment which focuses on growing a scalable and diversified portfolio of long-duration, permanent capital vehicles across corporate credit, specialty finance, real estate and other asset classes.

The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, including Great Elm Capital Management, Inc. (GECM), Great Elm Opportunities GP, Inc. (GEO GP), Great Elm Capital GP, LLC (GEC GP), Great Elm FM Acquisition, Inc. (FM Acquisition), Great Elm DME Holdings, Inc. (DME Holdings), Great Elm DME Manager, LLC (DME Manager), and Monomoy BTS Corporation (MBTS), as well as its majority-owned subsidiaries Forest Investments, Inc. (Forest) (through December 30, 2022) and Great Elm Healthcare, LLC (HC LLC) and its wholly-owned subsidiaries (through January 3, 2023). In addition, we have determined that the Company is the primary beneficiary of certain variable interest entities, and therefore the operations of those entities have been included in our consolidated results for the relevant periods.

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions for Form 10-Q and, therefore, do not include all information and footnotes that are normally included in the Company’s Form 10-K and should be read in conjunction with the audited consolidated financial statements and notes thereto, which are included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2022. These financial statements reflect all adjustments (consisting of normal recurring items or items discussed herein) that management believes are necessary to fairly state results for the interim periods presented. Results of operations for interim periods are not necessarily indicative of annual results of operations.

Previously reported assets and liabilities related to our Durable Medical Equipment (DME) Business, primarily consisting of HC LLC and its subsidiaries, have been reclassified as assets and liabilities held for sale on the Company's consolidated balance sheet as of June 30, 2022. In addition, the historical results of the DME Business and related activity have been presented in the accompanying unaudited condensed consolidated statements of operations for the three and nine months ended March 31, 2023 and 2022 as discontinued operations. See Note 4 – Assets and Liabilities Held for Sale and Discontinued Operations.
 

Use of Estimates

The preparation of these financial statements in accordance with accounting principles generally accepted in the United States of America (US GAAP) requires the Company to make estimates and assumptions that affect the reported amounts in the financial statements and disclosures of contingent assets and liabilities. On an on-going basis, the Company evaluates all of these estimates and assumptions. Included in these estimates and assumptions are items that relate to revenue recognition, impairment of long lived tangible and intangible assets, valuation allowance for deferred tax assets, fair value measurements including stock-based compensation and contingent consideration, and the value of lease liabilities and corresponding right of use assets. Although these and other estimates and assumptions are based on the best available information, actual results could be different from these estimates.

9


Principles of Consolidation

The Company consolidates the assets, liabilities, and operating results of its wholly-owned and majority-owned subsidiaries, as well as subsidiaries in which we hold a controlling financial interest as of the financial statement date. In most cases, a controlling financial interest reflects ownership of a majority of the voting interests. We consolidate a variable interest entity (VIE) when we possess both the power to direct the activities of the VIE that most significantly impact its economic performance and we are either obligated to absorb the losses that could potentially be significant to the VIE or we hold the right to receive benefits from the VIE that could potentially be significant to the VIE. All intercompany accounts and transactions have been eliminated in consolidation.

Non-controlling interests in the Company’s subsidiaries are reported as a component of liabilities for mandatorily redeemable interests, temporary equity for contingently redeemable interests or permanent equity, separate from the Company’s equity. See Note 11 – Non-Controlling Interests and Redeemable Preferred Stock of Subsidiaries. Results of operations attributable to the non-controlling interests are included in the Company’s condensed consolidated statements of operations.

Cash and Cash Equivalents

Cash and cash equivalents are comprised of cash and highly liquid investments with original maturities of 90 days or less at the date of purchase. Cash equivalents consist primarily of exchange-traded money market funds and the U.S. treasury bills. The Company is exposed to credit risk in the event of default by the financial institutions or the issuers of these investments to the extent the amounts on deposit or invested are in excess of amounts that are insured.

Real Estate under Development

Real estate under development is classified as follows: (i) real estate under development (current), which includes real estate projects that are in the process of being developed and expected to be completed and disposed of within one year of the balance sheet date; (ii) real estate under development (non-current), which includes real estate projects that are in the process of being developed and expected to be completed and disposed of more than one year from the balance sheet date; and (iii) real estate held for sale, which includes land and completed improvements thereon that meet all of the “held for sale” criteria.

Real estate under development is carried at cost less impairment, if applicable. We capitalize costs that are directly identifiable with the specific real estate projects, including pre-acquisition and pre-construction costs, development and construction costs, taxes, and insurance. We do not capitalize any general and administrative or overhead costs, regardless of whether the costs are internal or paid to third parties. Capitalization begins when the activities related to development have begun and ceases when activities are substantially complete and the asset is available for occupancy.

Real estate under development is evaluated for impairment and losses are recorded when undiscounted cash flows estimated to be generated by an asset are less than the asset’s carrying amount. The amount of the impairment loss, if any, is calculated as the excess of the asset’s carrying value over its fair value, which is determined using a discounted cash flow analysis, management estimates or market comparisons.

Real estate held for sale is recorded at the lower of cost or fair value less cost to sell. If an asset’s fair value less cost to sell, based on discounted future cash flows, management estimates or market comparisons, is less than its carrying amount, an allowance is recorded against the asset.


 


 

10


Earnings per Share

The following table presents the calculation of basic and diluted income (loss) per share:

 

 

For the three months ended March 31,

 

 

For the nine months ended March 31,

 

(in thousands except per share amounts)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income from continuing operations

 

$

(455

)

 

$

(6,467

)

 

$

19,735

 

 

$

(14,006

)

Less: net income (loss) attributable to non-controlling interest, continuing operations

 

 

-

 

 

 

1,146

 

 

 

(1,554

)

 

 

913

 

Numerator for basic EPS - Net (loss) income from continuing operations attributable to Great Elm Group, Inc.

 

$

(455

)

 

$

(7,613

)

 

$

21,289

 

 

$

(14,919

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income from discontinued operations

 

 

12,203

 

 

 

332

 

 

 

13,202

 

 

 

3,818

 

Less: net (loss) income attributable to non-controlling interest, discontinued operations

 

 

-

 

 

 

(1,372

)

 

 

1,504

 

 

 

(754

)

Numerator for basic EPS - Net (loss) income from discontinued operations, attributable to Great Elm Group, Inc.

 

$

12,203

 

 

$

1,704

 

 

$

11,698

 

 

$

4,572

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense associated with Convertible Notes, continuing operations

 

$

-

 

 

$

-

 

 

$

1,451

 

 

$

-

 

Numerator for diluted EPS - Net (loss) income from continuing operations attributable to Great Elm Group, Inc., after the effect of dilutive securities

 

$

(455

)

 

$

(7,613

)

 

$

22,740

 

 

$

(14,919

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator for diluted EPS - Net (loss) income from discontinued operations, attributable to Great Elm Group, Inc.

 

$

12,203

 

 

$

1,704

 

 

$

11,698

 

 

$

4,572

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Denominator for basic EPS - Weighted average shares of common stock outstanding

 

 

28,997

 

 

 

26,842

 

 

 

28,779

 

 

 

26,963

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock

 

 

-

 

 

 

-

 

 

 

1,328

 

 

 

-

 

Convertible Notes

 

 

-

 

 

 

-

 

 

 

10,566

 

 

 

-

 

Denominator for diluted EPS - Weighted average shares of common stock outstanding after the effect of dilutive securities

 

 

28,997

 

 

 

26,842

 

 

 

40,673

 

 

 

26,963

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per share from:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(0.02

)

 

$

(0.28

)

 

$

0.74

 

 

$

(0.55

)

Discontinued operations

 

 

0.42

 

 

 

0.06

 

 

 

0.41

 

 

 

0.17

 

Basic net income (loss) per share

 

$

0.40

 

 

$

(0.22

)

 

$

1.15

 

 

$

(0.38

)

Diluted income (loss) per share from:

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

(0.02

)

 

$

(0.28

)

 

$

0.56

 

 

$

(0.55

)

Discontinued operations

 

 

0.42

 

 

 

0.06

 

 

$

0.29

 

 

 

0.17

 

Diluted net income (loss) per share

 

$

0.40

 

 

$

(0.22

)

 

$

0.85

 

 

$

(0.38

)

As of March 31, 2023, the Company had 1,270,651 potential shares of common stock issuable upon the exercise of stock options that are not included in the diluted income (loss) per share calculation because to do so would be anti-dilutive for both the three and nine months ended March 31, 2023. As of March 31, 2023, the Company had 10,652,034 potential shares of common stock issuable upon the conversion of Convertible Notes (as defined below) and 1,522,443 potential shares issuable upon vesting of restricted stock units and restricted stock awards that are not included in the diluted income (loss) per share calculation for the three months ended March 31, 2023 because to do so would be anti-dilutive.

11


As of March 31, 2022, the Company had 10,139,031 potential shares of common stock issuable upon the conversion of Convertible Notes and 3,159,856 potential shares issuable upon the exercise of stock options and vesting of restricted stock units and restricted stock awards that are not included in the diluted income (loss) per share calculation because to do so would be anti-dilutive.

As of March 31, 2023 and 2022, the Company had an aggregate of 1,509,885 and 579,423 issued shares, respectively, that are not considered outstanding for accounting purposes since they are unvested and subject to forfeiture by the employees at a nominal price if service milestones are not met.

Recently Issued Accounting Standards

Current Expected Credit Losses. In June 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses (Topic 326), which changes the impairment model for financial instruments, including trade receivables from an incurred loss method to a new forward looking approach, based on expected losses. The estimate of expected credit losses will require entities to incorporate considerations of historical experience, current information and reasonable and supportable forecasts. The amendments in this ASU are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is evaluating the potential impact that the adoption of this ASU will have on its consolidated financial statements.

Reference Rate Reform. In March 2020 and January 2021, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, and ASU 2021-01, Reference Rate Reform (Topic 848): Scope, which provide optional expedients and exceptions for applying US GAAP to contracts, hedging relationships and other transactions affected by reference rate reform on financial reporting due to the cessation of the London Interbank Offered Rate (LIBOR) if certain criteria are met. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848, extending the sunset date under Topic 848 from December 31, 2022 to December 31, 2024 to align the temporary accounting relief guidance with the expected LIBOR cessation date of June 30, 2023. The Company is evaluating the potential impact that the adoption of these ASUs will have on its consolidated financial statements.

3. Forest Note and Transactions with JPM

Forest Note

On December 29, 2022, in connection with the Stock Purchase Agreement and Stockholders Agreement, each defined below, GEG and FM Acquisition issued a promissory note in favor of Forest in an aggregate principal amount equal to $38.1 million (the Forest Note), in exchange for the transfer to FM Acquisition of $3.3 million of Series A-1 preferred interests and $34.0 million of Series A-2 preferred interests held by Forest in HC LLC plus, in each case, accrued dividends thereon to the date of transfer. The Forest Note had a maturity date of March 1, 2023 and bore interest at a fixed rate of 9% per annum.

On December 30, 2022, in connection with the Transactions with JPM, as defined below, the Company partially repaid the Forest Note in the amount of $18.4 million. As of December 31, 2022, the remaining balance, inclusive of accrued interest, due to Forest under the Forest Note was $19.7 million, which was subsequently paid in full on January 3, 2023 using the proceeds from the Sale of HC LLC (see Note 4 - Assets and Liabilities Held for Sale and Discontinued Operations).

During the three and nine months ended March 31, 2023, the Company recorded interest expense of approximately $10 thousand and $19 thousand, respectively, with respect to the Forest Note.

12


Sale of Controlling Interest in Forest

On December 30, 2022, GEG and FM Acquisition, entered into a stock purchase agreement (the Stock Purchase Agreement) with J.P. Morgan Broker-Dealer Holdings Inc. (JPM) to sell 61 shares of the common stock, $0.001 par value per share, of Forest owned by FM Acquisition and GEG, which constitute 61% of the issued and outstanding shares of Forest’s common stock, to JPM for approximately $18.4 million in cash (the Sale of Controlling Interest in Forest). Upon execution of the Stock Purchase Agreement, the Company deconsolidated Forest and recognized an investment in respect to its retained 19% non-controlling interest in Forest (the Investment in Forest) in the amount of $2.1 million. The following table shows calculation of the recorded gain on sale of controlling interest in subsidiary of $10.5 million on the Company's condensed consolidated statement of operations for the nine months ended March 31, 2023:

(in thousands)

 

December 30, 2022

 

Cash proceeds

 

$

18,409

 

Fair value of retained 19% non-controlling interest in Forest

 

 

2,128

 

Carrying value of non-controlling interest prior to sale

 

 

2,120

 

 

 

 

22,657

 

Less: Carrying value of net assets disposed

 

 

12,133

 

Gain on Sale of Controlling Interest in Forest

 

$

10,524

 

 

The Investment in Forest was determined to be an equity security measured at fair value within Level 3 of the fair value hierarchy. As a result of Forest joining the JPM consolidated group, we recognized an unrealized gain on our Investment in Forest of $24.4 million during the three and six months ended December 31, 2022 within net realized and unrealized gain (loss) on investments on the consolidated statements of operations.

The Sale of Controlling Interest in Forest did not meet the criteria for presentation as discontinued operations. The following table shows loss before income taxes of Forest, as well as loss before income taxes of Forest attributable to Great Elm Group, Inc.:

 

 

For the three months ended March 31,

 

 

For the nine months ended March 31,

 

(in thousands)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Loss before income taxes

 

 

-

 

 

 

(482

)

 

 

(2,679

)

 

 

(1,442

)

Loss before income taxes attributable to Great Elm Group, Inc.

 

 

-

 

 

 

(1,726

)

 

 

(1,133

)

 

 

(2,508

)

 

13


 

Put Option

In connection with the Stock Purchase Agreement, GEG, JPM and Forest entered into an amended and restated stockholders’ agreement (the Stockholders Agreement). Pursuant to the Stockholders Agreement, from January 17, 2023 until February 17, 2023, GEG had the right (the Put Option, together with the Sale of Controlling Interest in Forest referred to as the Transactions with JPM) to sell the Investment in Forest for the then fair market value. On January 17, 2023, the Company exercised the Put Option and sold the Investment in Forest for $26.5 million in cash, resulting in the total realized gain on our Investment in Forest for three and nine months ended March 31, 2023 of $24.4 million recorded within net realized and unrealized gain (loss) on investments on the consolidated statements of operations.

4. Assets and Liabilities Held for Sale and Discontinued Operations

On January 3, 2023, DME Holdings along with the minority owners of HC LLC, entered into a purchase agreement with QHM Holdings, Inc., a subsidiary of Quipt Home Medical Corp. (Quipt), to sell 100% of the outstanding membership interests in HC LLC to Quipt (Sale of HC LLC) for $80.0 million, consisting of approximately $72.8 million in cash, $5.2 million of indebtedness assumed by Quipt and $2.0 million in shares of Quipt common stock based on the 20-day volume-weighted average price of Quipt’s common stock for the period ending on and including the second business day prior to the closing of the transaction. After transaction costs of $2.5 million, distributions to non-controlling interests of $5.9 million, and indemnity escrow payment of $0.4 million, cash proceeds to GEG and subsidiaries were $64.1 million. The following table shows calculation of the recorded gain on Sale of HC LLC of $13.6 million:

(in thousands)

 

January 3, 2023

 

Net cash proceeds, after transaction costs and distributions to non-controlling interests

 

$

64,093

 

Fair value of shares of Quipt stock

 

 

2,000

 

Indemnity escrow receivable attributable to GEG and subsidiaries

 

 

320

 

Carrying value of non-controlling interest prior to sale (permanent equity)

 

 

2,977

 

Carrying value of non-controlling interest prior to sale (temporary equity)

 

 

2,977

 

Estimated future distributions of proceeds to non-controlling interests

 

 

(1,144

)

 

 

 

71,223

 

Less: Carrying value of net assets disposed

 

 

57,671

 

Gain on Sale of HC LLC

 

$

13,552

 

 

14


 

The Company concluded that the disposal group satisfied the criteria for presentation as held for sale and discontinued operations as of December 31, 2022. The following table provides a reconciliation of the Company’s net income from discontinued operations presented in the condensed consolidated statements of operations:

 

 

For the three months ended March 31,

 

 

For the nine months ended March 31,

 

(in thousands)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

Durable medical equipment sales and services revenue

 

$

-

 

 

$

10,359

 

 

$

21,574

 

 

$

30,712

 

Durable medical equipment rental income

 

 

-

 

 

 

5,275

 

 

 

11,874

 

 

 

16,205

 

Net revenue

 

 

-

 

 

 

15,634

 

 

 

33,448

 

 

 

46,917

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of durable medical equipment sold and services

 

 

-

 

 

 

(4,362

)

 

 

(8,654

)

 

 

(12,731

)

Cost of durable medical equipment rentals

 

 

-

 

 

 

(1,708

)

 

 

(4,263

)

 

 

(5,292

)

Durable medical equipment other operating expenses

 

 

-

 

 

 

(8,758

)

 

 

(17,519

)

 

 

(23,327

)

Depreciation and amortization

 

 

-

 

 

 

(428

)

 

 

(783

)

 

 

(1,324

)

Transaction costs

 

 

(1,023

)

 

 

-

 

 

 

(2,462

)

 

 

(224

)

Gain on sale of subsidiary

 

 

13,552

 

 

 

-

 

 

 

13,552

 

 

 

-

 

Interest expense

 

 

-

 

 

 

(68

)

 

 

(46

)

 

 

(206

)

Loss on distinguishment of debt

 

 

-

 

 

 

-

 

 

 

(23

)

 

 

-

 

Other income (expense), net

 

 

(202

)

 

 

-

 

 

 

(192

)

 

 

2

 

Income before income taxes from discontinued operations

 

 

12,327

 

 

 

310

 

 

 

13,058

 

 

 

3,815

 

Income tax (expense) benefit

 

 

(124

)

 

 

22

 

 

 

144

 

 

 

3

 

Net income from discontinued operations

 

$

12,203

 

 

$

332

 

 

$

13,202

 

 

$

3,818

 

 

The following table provides a reconciliation of the assets and liabilities held for sale presented in the condensed consolidated balance sheet as of June 30, 2022:

(in thousands)

 

June 30, 2022

 

Cash and cash equivalents

 

$

1,314

 

Accounts receivable

 

 

5,867

 

Inventories

 

 

898

 

Prepaid and other current assets

 

 

385

 

Current assets held for sale

 

$

8,464

 

 

 

 

 

Property and equipment, net

 

$

521

 

Equipment held for rental, net

 

 

7,504

 

Identifiable intangible assets, net

 

 

5,921

 

Goodwill

 

 

52,463

 

Right of use assets

 

 

2,989

 

Other assets

 

 

163

 

Non-current assets held for sale

 

$

69,561

 

 

 

 

 

Accounts payable

 

$

6,030

 

Accrued expenses and other liabilities

 

 

3,544

 

Deferred revenue

 

 

1,218

 

Current portion of lease liabilities

 

 

1,218

 

Current portion of equipment financing debt

 

 

2,993

 

Current liabilities held for sale

 

$

15,003

 

 

 

 

 

Lease liabilities, net of current portion

 

$

1,903

 

Redeemable preferred stock of subsidiaries

 

 

648

 

Non-current liabilities held for sale

 

$

2,551

 

 

15


 

 

5. Revenue

The revenues from each major source are summarized in the following table:

 

 

For the three months ended March 31,

 

 

For the nine months ended March 31,

 

(in thousands)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Management fees

 

$

1,384

 

 

$

779

 

 

$

4,067

 

 

$

2,550

 

Property management fees

 

 

278

 

 

 

-

 

 

 

830

 

 

 

-

 

Administration and service fees

 

 

236

 

 

 

209

 

 

 

740

 

 

 

442

 

Total revenues

 

$

1,898

 

 

$

988

 

 

$

5,637

 

 

$

2,992

 

 

The Company recognizes investment management revenue at amounts that reflect the consideration to which it expects to be entitled in exchange for providing services to its customers. Investment management revenue primarily consists of fees based on a percentage of assets under management, fees based on the performance of managed assets, and administration and service fees. Fees are based on agreements with each investment product and may be terminated at any time by either party subject to the specific terms of each respective agreement.

Management Fees

The Company earns management fees based on the investment management agreements GECM has with Great Elm Capital Corp. (GECC), Monomoy Properties UpREIT, LLC, the operating partnership of Monomoy Properties REIT, LLC (Monomoy UpREIT) and other private funds managed by GECM (collectively, the Funds). The performance obligation is satisfied and management fee revenue is recognized over time as the services are rendered, since the Funds simultaneously receive and consume the benefits provided as GECM performs services. Management fee rates range from 1.0% to 1.5% of the management fee assets specified within each agreement and are calculated and billed in arrears of the period, either monthly or quarterly.

Property Management Fees

Under the Monomoy UpREIT investment management agreement, GECM is also entitled to 4.0% of rent collected. These fees are collected monthly in arrears. Property management fee revenue is recognized over time as the services are provided.

Incentive Fees

The Company earns incentive fees based on the investment management agreements GECM has with GECC and Monomoy Properties II, LLC (MP II), a feeder fund of Monomoy Properties REIT, LLC. Where an investment management agreement includes both management fees and incentive fees, the performance obligation is considered to be a single obligation for both fees. Incentive fees are variable consideration associated with the investment management agreements. Incentive fees are earned based on investment performance during the period, subject to the achievement of minimum return levels or high-water marks, in accordance with the terms of the respective investment management agreements. Incentive fees are typically 20% of the performance-based metric specified within each agreement. As of March 31, 2023, there was $1.3 million in incentive fees which have been earned per the terms of the respective investment management agreements but not recognized as they are still subject to the constraints described above.

16


Administration and Service Fees

The Company earns administration fees based on the administration agreement GECM has with GECC whereby the investment vehicles reimburse GECM for costs incurred in performing certain administrative functions. This revenue is recognized over time as the services are performed. Administration fees are billed quarterly in arrears, which is consistent with the timing of the delivery of services and reflect agreed upon rates for the services provided. The services are accounted for as a single performance obligation for each investment vehicle that is a series of distinct services with substantially the same pattern of transfer as the services are provided on a daily basis.

6. Related Party Transactions

Related party transactions are measured in part by the amount of consideration paid or received as established and agreed by the parties. Consideration paid for such services in each case is the negotiated value.

The Company’s wholly-owned subsidiary, GECM, has agreements to provide administrative services and manage the investment portfolio for GECC, Monomoy UpREIT and other investment products. Under these agreements, GECM receives administration fees, management fees based on the managed assets (other than cash and cash equivalents) and rent collected, and incentive fees based on the performance of those assets. See Note 5 – Revenue for additional discussions of the fee arrangements.

The Company’s wholly-owned subsidiary, GEO GP, serves as the general partner of Great Elm Opportunities Fund I, LP (GEOF), a Delaware multi-series limited partnership. GECM serves as the investment manager of GEOF. As the general partner, GEO GP provides administrative services and oversees GECM’s management of the investment portfolio of GEOF.

The Company determined that GEOF and Series A, Series B and Series C of GEOF are VIEs, and that the criteria for consolidation were only met for GEOF Series C, which was launched in November 2020 and subsequently merged into GESOF (as defined below). GEOF Series D was launched on January 1, 2023 and the Company determined that it was not a VIE. The contribution in the amount of $3.0 million made by GEG into GEOF Series D with the subscription date of January 1, 2023 was determined to be an equity method investment and the Company elected the fair value option using the net asset value (NAV) practical expedient for this instrument with all changes in NAV reported in net realized and unrealized gain (loss) on investments on the statement of operations.

GECM also served as the managing member of Great Elm SPAC Opportunity Fund, LLC (GESOF or the Consolidated Fund), a Delaware limited liability company, which was launched in February 2021, and provided administrative services and managed the investment portfolio of GESOF. The Company determined that GESOF was a VIE and that the criteria for consolidation were met during the nine months ended March 31, 2023 (through the date of its dissolution in July 2022) and the three and nine months ended March 31, 2022. The operations of the Consolidated Fund are included in our consolidated financial statements. In July 2022, GESOF liquidated and the Company received a distribution of cash and equity investments, pending final dissolution of the Consolidated Fund.

There are no consolidated funds as of March 31, 2023. See Note 2 – Summary of Significant Accounting Policies for additional details.

The Company retained the specialized investment company accounting guidance under US GAAP with respect to the Consolidated Fund during the periods it was consolidated. As such, investments of the Consolidated Fund were included in the condensed consolidated balance sheets at fair value and the net realized and unrealized gain or loss on those investments was included as a component of other income on the condensed consolidated statements of operations. Non-controlling interests in the Consolidated Fund were included in net income (loss) attributable to non-controlling interest, continuing operations.

Additionally, the Company receives dividends from its investment in GECC and Monomoy UpREIT and earns unrealized gains and losses based on the mark-to-market performance of those investments. See Note 7 – Fair Value Measurements.

17


The following tables summarize activity and outstanding balances between the managed investment products and the Company:

 

 

For the three months ended March 31,

 

 

For the nine months ended March 31,

 

 (in thousands)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net realized and unrealized gain (loss) on investments

 

$

895

 

 

$

(3,474

)

 

$

(7,950

)

 

$

(5,838

)

Net realized and unrealized loss on investments of Consolidated Fund

 

 

-

 

 

 

(284

)

 

 

(16

)

 

 

(279

)

Dividend income

 

 

849

 

 

 

549

 

 

 

3,510

 

 

 

1,651

 

 

 (in thousands)

 

March 31, 2023

 

 

June 30, 2022

 

Dividends receivable

 

$

300

 

 

$

612

 

Investment management revenues receivable

 

 

1,136

 

 

 

1,241

 

Receivable for reimbursable expenses paid

 

 

985

 

 

 

592

 

Receivables from managed funds

 

$

2,421

 

 

$

2,445

 

Outstanding receivables are included in receivables from managed funds in the condensed consolidated balance sheets.

The Company owns 1,569,787 shares of GECC (approximately 20.6% of the outstanding shares). Certain officers and directors of GECC are also officers and directors of GEG. Matthew A. Drapkin is a director of our Board of Directors and also the Chairman of GECC's Board of Directors, and Adam M. Kleinman is our President, as well as the Chief Compliance Officer of GECC.

In October 2020, GECM entered into a shared personnel and reimbursement agreement with Imperial Capital Asset Management, LLC (ICAM). Jason W. Reese, the Executive Chairman of the Company’s Board of Directors, is the Chief Executive Officer of ICAM. Costs incurred under this agreement relate to human resources, investment management, and other administrative services provided by ICAM employees, for the benefit of the Company, and are included in investment management expenses in the condensed consolidated statements of operations. During the three and nine months ended March 31, 2023 such costs were $0.4 million and $1.1 million, respectively. During the three and nine months ended March 31, 2022 such costs were $0.4 million and $0.7 million, respectively.

On August 31, 2021, the Company entered into a financial advisory agreement with Imperial Capital, LLC. The agreement included a retainer fee of $0.1 million which was paid in October 2021. In addition, the agreement included a success-based fee upon a sale of HC LLC. Upon completion of the Sale of HC LLC on January 3, 2023, a success fee of $0.7 million was paid to Imperial Capital, LLC. Jason W. Reese is the Co-Founder of Imperial Capital, LLC.

See Note 3 - Forest Note and Transactions with JPM for details on the Forest Note and Investment in Forest.

18


7. Fair Value Measurements

Fair value is defined as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.

US GAAP provides a framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value:

Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
Level 2: Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3: Unobservable inputs reflecting the Company’s own assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

All financial assets or liabilities that are measured at fair value on a recurring and non-recurring basis have been segregated into the most appropriate level within the fair value hierarchy based on the inputs used to determine the fair value at the measurement date. The assets and liabilities measured at fair value on a recurring and non-recurring basis are summarized in the tables below:

 

 

Fair Value as of March 31, 2023

 

 

(in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity investments

 

$

17,282

 

 

$

-

 

 

$

-

 

 

$

17,282

 

 

Total assets within the fair value hierarchy

 

$

17,282

 

 

$

-

 

 

$

-

 

 

$

17,282

 

 

Investments valued at net asset value

 

 

 

 

 

 

 

 

 

 

$

17,822

 

 

Total assets

 

 

 

 

 

 

 

 

 

 

$

35,104

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liability

 

$

-

 

 

$

-

 

 

$

1,300

 

 

$

1,300

 

 

Total liabilities

 

$

-

 

 

$

-

 

 

$

1,300

 

 

$

1,300

 

 

 

 

 

Fair Value as of June 30, 2022

 

 

(in thousands)

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity investments

 

$

27,678

 

 

$

-

 

 

$

-

 

 

$

27,678

 

 

Equity investments of Consolidated Fund

 

 

1,797

 

 

 

-

 

 

 

-

 

 

 

1,797

 

 

Total assets within the fair value hierarchy

 

$

29,475

 

 

$

-

 

 

$

-

 

 

$

29,475

 

 

Investments valued at net asset value

 

 

 

 

 

 

 

 

 

 

$

20,364

 

 

Total assets

 

 

 

 

 

 

 

 

 

 

$

49,839

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

Contingent consideration liability

 

$

-

 

 

$

-

 

 

$

1,120

 

 

$

1,120

 

 

Total liabilities

 

$

-

 

 

$

-

 

 

$

1,120

 

 

$

1,120

 

 

 

19


There were no transfers between levels of the fair value hierarchy during the three and nine months ended March 31, 2023 and 2022.

The following is a reconciliation of changes in contingent consideration, a Level 3 liability:

(in thousands)

 

For the three months ended March 31, 2023

 

 

For the nine months ended March 31, 2023

 

Beginning balance

 

$

1,180

 

 

$

1,120

 

Change in fair value

 

 

120

 

 

 

180

 

Ending balance

 

$

1,300

 

 

$

1,300

 

The valuation techniques applied to investments held by the Company and by the Consolidated Fund varied depending on the nature of the investment.

Equity and equity-related securities

Securities traded on a national securities exchange are stated at the close price on the valuation date. To the extent these securities are actively traded and valuation adjustments are not applied, they are classified as Level 1.

Investments in private funds

The Company values investments in private funds using NAV as reported by each fund’s investment manager. The private funds calculate NAV in a manner consistent with the measurement principles of FASB Accounting Standards Codification (ASC) Topic 946, Financial Services – Investment Companies, as of the valuation date. Investments valued using NAV as a practical expedient are not categorized within the fair value hierarchy.

As of March 31, 2023, investments in private funds primarily consisted of our investment in Monomoy UpREIT and GEOF Series D. As of June 30, 2022, investments in private funds primarily consisted of our investment in Monomoy UpREIT. Monomoy UpREIT allows redemptions annually with 90 days’ notice, subject to a one-year lockup from the date of initial investment, which are capped at 5% of its NAV. GEOF Series D allows withdrawals annually and there is no set duration for the private fund. As of March 31, 2023, there were no unfunded commitments.

Contingent consideration

In conjunction with the acquisition of the Monomoy UpREIT investment management agreement, the Company entered into a contingent consideration agreement that requires the Company to pay up to $2.0 million if certain fee revenue thresholds are achieved during fiscal years ending June 30, 2023 and 2024. The Company estimated the fair value of the contingent consideration using a Monte Carlo simulation model. The key assumptions in applying the Monte Carlo simulation model as of March 31, 2023 and June 30, 2022 included revenue forecasts, volatility of 20.2% and 19.6%, respectively, and a discount rate of 7.75% and 6.5%, respectively. As of March 31, 2023, the contingent consideration of $1.3 million was included within the current portion of related party payables and related party payables in the condensed consolidated balance sheet. As of June 30, 2022, the contingent consideration of $1.1 million was included within the related party payables in the condensed consolidated balance sheet.

See Note 9 - Borrowings for additional discussion related to the fair value of our notes payable and other long-term debt. The carrying value of all other financial assets and liabilities approximate their fair values.

20


8. Real Estate under Development

In January 2023, MBTS completed purchases of certain land parcels located in Canton, Mississippi, and Midway, Florida. Contemporaneously with the land purchases, MBTS entered into commercial lease agreements, as a lessor, in respect to the land parcels and build-to-suit improvements to be constructed thereon. The leases will commence upon substantial completion of the build-to-suit development, which is expected not later than the first calendar quarter of 2024. We intend to sell the land and improvements with the attached leases at or close to the respective lease commencement date.

During the three and nine months ended March 31, 2023, the Company capitalized costs of $1.7 million within real estate under development (current) on its balance sheet, representing the cost of land and development and construction costs directly identifiable with the two real estate projects.

9. Borrowings

As of March 31, 2023, the Company did not have any outstanding related party borrowings. Related party borrowings of the Company's subsidiaries as of June 30, 2022, are summarized in the following table:

(in thousands)

 

Borrower

June 30, 2022

 

Seller Note

 

GECM

$

6,270

 

Total principal

 

 

$

6,270

 

Unamortized debt issuance cost

 

 

 

-

 

Total related party notes payable

 

 

 

 

6,270

 

Less current portion of related party notes payable

 

 

 

 

-

 

Related party notes payable, net of current portion

 

 

$

6,270

 

The Company’s and subsidiaries’ other outstanding borrowings are summarized in the following table:

(in thousands)

 

Borrower

March 31, 2023

 

June 30, 2022

 

GEGGL Notes

 

GEG

$

26,945

 

$

26,945

 

Total principal

 

 

$

26,945

 

$

26,945

 

Unamortized debt discounts and issuance costs

 

 

 

(1,208

)

 

(1,413

)

Long term debt

 

 

 

 

25,737

 

 

 

25,532

 

During the three and nine months ended March 31, 2023, the Company incurred interest expense of $0.6 million and $1.9 million, respectively, on related-party and other borrowings. During the three and nine months ended March 31, 2022, the Company did not have any related-party or other borrowings. See Note 10 – Convertible Notes for interest expense on Convertible Notes and Note 11 – Non-Controlling Interests and Redeemable Preferred Stock of Subsidiaries for interest expense on the preferred stock of subsidiaries.

The Company’s aggregate future required principal debt repayments are summarized in the following table:

(in thousands)

Principal Due

 

For the three months ending June 30, 2023

$

-

 

For the year ending June 30, 2024

 

-

 

For the year ending June 30, 2025

 

-

 

For the year ending June 30, 2026

 

-

 

For the year ending June 30, 2027

 

 

26,945

 

Thereafter

 

-

 

Total

$

26,945

 

 

21


Additional details of each borrowing are discussed below.

Seller Note

On May 4, 2022 as part of the consideration paid to acquire the Monomoy UpREIT investment management agreement, GECM issued ICAM a $6.3 million promissory note (the Seller Note). The Seller Note was due on August 4, 2023 and had no prepayment penalties. The Seller Note bore interest of 6.5% per annum, which was paid quarterly.

In August and December 2022, the Company settled the principal amount of $0.6 million and $2.0 million, respectively, by transferring 50,000 and 200,000 shares of GECC stock, respectively. In February 2023, the Company repaid the remaining principal of $3.7 million in full.

GEGGL Notes

On June 9, 2022, we issued $26.9 million in aggregate principal amount of 7.25% notes due 2027 (the GEGGL Notes), which included $1.9 million of GEGGL Notes issued in connection with the partial exercise of the underwriters’ over-allotment option. The GEGGL Notes are unsecured obligations and rank: (i) pari passu, or equal, with the Convertible Notes and any future outstanding unsecured unsubordinated indebtedness; (ii) senior to any of our indebtedness that expressly provides it is subordinated to the GEGGL Notes; (iii) effectively subordinated to any future secured indebtedness; and (iv) structurally subordinated to any future indebtedness and other obligations of any of our current and future subsidiaries. We pay interest on the GEGGL Notes on March 31, June 30, September 30 and December 31 of each year. The GEGGL Notes will mature on June 30, 2027. The GEGGL Notes can be called on, or after, June 30, 2024. Holders of the GEGGL Notes do not have the option to have the notes repaid prior to the stated maturity date. The GEGGL Notes were issued in minimum denominations of $25 and integral multiples of $25 in excess thereof.

The GEGGL Notes include covenants that limit additional indebtedness or the payment of dividends subject to compliance with a net consolidated debt to equity ratio of 2:1. As of March 31, 2023 our net consolidated debt to equity ratio is -0.29:1.00.

10. Convertible Notes

As of March 31, 2023 and June 30, 2022, the total outstanding principal balance of convertible notes due on February 26, 2030 (the Convertible Notes) was $37.0 million and $36.1 million, respectively, including cumulative interest paid in-kind. The Convertible Notes are held by a consortium of investors, including $15.0 million issued to certain related parties as of March 31, 2023.

The Convertible Notes accrue interest at 5.0% per annum, payable semiannually in arrears on June 30 and December 31, commencing June 30, 2020, in cash or in kind at the option of the Company. Each $1,000 principal amount of the Convertible Notes are convertible into 288.0018 shares of the Company’s common stock, subject to the terms therein, prior to maturity at the option of the holder.

The Company may, subject to compliance with the terms of the Convertible Notes, effect the conversion of some or all of the Convertible Notes into shares of common stock, subject to certain liquidity and pricing requirements, as specified in the Convertible Notes.

The embedded conversion feature in the Convertible Notes qualifies for the scope exception to derivative accounting in FASB ASC Topic 815, Derivatives and Hedging, for certain contracts involving a reporting entity’s own equity. The Company incurred $1.2 million in issuance costs on the original issuance. The debt issuance costs are being amortized over the 10-year term and are netted with the principal balance on our condensed consolidated balance sheets. As of March 31, 2023 and June 30, 2022, the remaining balance of unamortized debt issuance costs was $0.8 million and $0.9 million, respectively.

22


During the three and nine months ended March 31, 2023, the Company incurred interest expense of $0.5 million and $1.5 million, respectively, related to the Convertible Notes, inclusive of non-cash interest related to amortization of debt issuance costs. During the three and nine months ended March 31, 2022, the Company incurred interest expense of $0.4 million and $1.3 million, respectively, related to the Convertible Notes, inclusive of non-cash interest related to amortization of debt issuance costs.

11. Non-Controlling Interests and Redeemable Preferred Stock of Subsidiaries

Non-Controlling Interests

Holders of non-controlling interests in a subsidiary of the Company hold certain rights, which result in the classification of the securities as either liability, temporary equity, or permanent equity. The following table summarizes the non-controlling interest balances on the condensed consolidated balance sheets:

(in thousands)

 

March 31, 2023

 

June 30, 2022

 

HC LLC

 

 

 

 

 

 

Temporary equity

 

 

-

 

 

 

2,225

 

Permanent equity

 

 

-

 

 

 

2,225

 

Total HC LLC

 

 

-

 

 

 

4,450

 

Consolidated Fund

 

 

 

 

 

 

Permanent equity

 

 

-

 

 

 

642

 

Forest

 

 

 

 

 

 

Permanent equity

 

 

-

 

 

 

3,666

 

Total non-controlling interests

 

$

-

 

 

$

8,758

 

The following table summarizes the net (loss) income attributable to the non-controlling interests on the condensed consolidated statements of operations:

 

 

For the three months ended March 31,

 

 

For the nine months ended March 31,

 

(in thousands)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

HC LLC

 

 

 

 

 

 

 

 

 

 

 

 

Temporary equity

 

 

-

 

 

 

(686

)

 

 

752

 

 

 

(377

)

Permanent equity

 

 

-

 

 

 

(686

)

 

 

752

 

 

 

(377

)

Total HC LLC

 

 

-

 

 

 

(1,372

)

 

 

1,504

 

 

 

(754

)

GEC GP

 

 

 

 

 

 

 

 

 

 

 

 

Permanent equity

 

 

-

 

 

 

(3

)

 

 

-

 

 

 

(7

)

Consolidated Fund

 

 

 

 

 

 

 

 

 

 

 

 

Permanent equity

 

 

-

 

 

 

(95

)

 

 

(8

)

 

 

(146

)

Forest

 

 

 

 

 

 

 

 

 

 

 

 

Permanent equity

 

 

-

 

 

 

1,244

 

 

 

(1,546

)

 

 

1,066

 

Total net (loss) income attributable to non-controlling interest

 

$

-

 

 

$

(226

)

 

$

(50

)

 

$

159

 

 

23


 

HC LLC – Non-controlling interest classified as temporary equity

The Company issued a 9.95% common stock equity ownership in HC LLC. The holder of the interest had board observer rights for the HC LLC board of directors, but no voting rights. HC LLC had the right of first offer if the holder desired to sell the security and in the event of a sale of HC LLC, the holder was obligated to sell their securities (drag along rights) and had the right to participate in sales of HC LLC securities (tag along rights). In addition, upon the seventh anniversary of issuance date, if (i) the holder owned at least 50% of the common shares issued to it at the closing of the transaction, (ii) an initial public offering of HC LLC had not commenced and (iii) the holder had not had an earlier opportunity to sell its shares at their fair market value, the holder had the right to request a marketing process for a sale of HC LLC and had the right to put its common shares to HC LLC at the price for such shares implied by such marketing process. The Company also had the right to call the holder’s common shares at such price. The holder of the non-controlling interest was entitled to participate in earnings of HC LLC and was not required to fund losses. As the redemption was contingent upon future events outside of the Company’s control which were not probable, the Company classified the non-controlling interest as temporary equity at its fair value on the date of issuance, adjusted for any earnings in HC LLC. As of March 31, 2023, no non-controlling interest was outstanding following the Sale of HC LLC on January 3, 2023. Refer to Note 4 - Assets and Liabilities Held for Sale and Discontinued Operations for details on the Sale of HC LLC to Quipt.

HC LLC – Non-controlling interest classified as permanent equity

The Company issued a 9.95% common stock equity ownership in HC LLC. The rights were consistent with the non-controlling interest classified as temporary equity, other than the holder not having a contingent put right. Accordingly, the Company classified the non-controlling interest as permanent equity at its fair value on the date of issuance, adjusted for any earnings in HC LLC. As of March 31, 2023, no non-controlling interest was outstanding following the Sale of HC LLC on January 3, 2023. Refer to Note 4 - Assets and Liabilities Held for Sale and Discontinued Operations for details on the Sale of HC LLC to Quipt.
 

GEC GP – Non-controlling interest classified as permanent equity

GEC GP owned the rights to the profit sharing agreement with GECM as well as an intercompany obligation under a senior secured note payable issued by Great Elm GECC GP Corp in consideration for the assets acquired from MAST Capital Management, LLC. During the three months ended March 31, 2022, the Company purchased the remaining shares of GEC GP. As of March 31, 2023, no non-controlling interest was outstanding.

Forest – Non-controlling interest classified as permanent equity

In December 2020, the Company sold to JPM a 20.0% common stock interest in Forest in exchange for $2.7 million. As of March 31, 2023, no non-controlling interest was outstanding following the Sale of Controlling Interest in Forest. See Note 3 - Forest Note and Transactions with JPM.

Consolidated Fund – Non-controlling interest classified as permanent equity

As of June 30, 2022, the Company held 73.4% of the capital in the Consolidated Fund. The remaining capital in the Consolidated Fund was recorded as a non-controlling interest that included affiliated individuals and entities. In July 2022, the Consolidated Fund ceased operations and distributed its remaining assets to non-controlling interests in the total amount of $0.6 million.

24


Redeemable Preferred Stock of Subsidiaries

Forest Preferred Stock classified as a liability

On December 29, 2020, Forest issued 35,010 shares of preferred stock in Forest with a face value of $1,000 per share at issuance (Forest Preferred Stock). The preferred shares provided for a 9% annual dividend, which was payable quarterly. As the preferred shares were mandatorily redeemable by the Company at their face value of $1,000 per share on December 29, 2027, or at a 0-3% premium decreasing over time based upon the occurrence of certain redemption events prior to December 29, 2027, the security was classified as a liability in the condensed consolidated balance sheet as of June 30, 2022. Following the Sale of Controlling Interest in Forest on December 30, 2022, there was no outstanding balance in respect to Forest Preferred Stock. See Note 3 - Forest Note and Transactions with JPM.

The dividends on Forest Preferred Stock were included in interest expense in the condensed consolidated statements of operations. During the nine months ended March 31, 2023, the Company recorded interest expense, inclusive of non-cash interest related to amortization of discounts and debt issuance costs, of $1.7 million related to Forest Preferred Stock. No interest expense was recorded during the three months ended March 31, 2023 following the Sale of Controlling Interest in Forest on December 30, 2022. During the three and nine months ended March 31, 2022, the Company recorded interest expense, inclusive of non-cash interest related to amortization of discounts and debt issuance costs, of $0.8 million and $2.5 million, respectively, related to Forest Preferred Stock.

12. Stockholders’ Equity

Restricted Stock Awards and Restricted Stock Units

Restricted stock awards have vesting terms between 1-3 years and are subject to service requirements. During the three and nine months ended March 31, 2023, the Company granted 563,351 and 963,299 restricted stock awards, respectively.

Restricted stock units are subject to service requirements. During the three and nine months ended March 31, 2023 the Company did not grant any shares of restricted stock units.

The Company accounts for forfeitures of the restricted stock awards and restricted stock units in the period occurred.

The activity of the Company’s restricted stock awards and restricted stock units for the nine months ended March 31, 2023 was as follows:

Restricted Stock Awards and Restricted Stock Units

 

Restricted Stock
(in thousands)

 

 

Weighted Average Grant Date Fair Value

 

Outstanding at June 30, 2022

 

 

1,312

 

 

$

1.79

 

Granted

 

 

963

 

 

 

2.20

 

Vested

 

 

(581

)

 

 

2.15

 

Forfeited

 

 

(5

)

 

 

3.07

 

Outstanding at March 31, 2023

 

 

1,689

 

 

$

1.90

 

 

25


Non-Employee Director Deferred Compensation Plan

In December 2020, the Company established the Great Elm Group, Inc. Non-Employee Directors Deferred Compensation Plan allowing non-employee directors to defer their cash and/or equity compensation under a non-revocable election for each calendar year. Such compensation is deferred until the earlier of 3 years from the original grant date of such compensation, termination of service, or death, and is payable in common stock shares. As of March 31, 2023, there were 167,939 restricted stock awards and restricted stock units that were deferred under this plan (and thus included in the number of restricted stock awards and restricted stock units outstanding as of that date), including 57,931 restricted stock awards, for which the service condition was met during the nine months ended March 31, 2023.

Stock Options

The following table summarizes the Company’s option award activity as of and during the nine months ended March 31, 2023:

Options

 

Shares
(in thousands)

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value
(in thousands)

 

Outstanding at June 30, 2022

 

 

2,134

 

 

$

3.68

 

 

 

3.34

 

 

$

-

 

Options granted

 

 

125

 

 

 

3.60

 

 

 

-

 

 

 

-

 

Forfeited, cancelled or expired

 

 

(988

)

 

 

3.63

 

 

 

-

 

 

 

-

 

Outstanding at March 31, 2023

 

 

1,271

 

 

$

3.72

 

 

 

4.19

 

 

$

-

 

Exercisable at March 31, 2023

 

 

1,439

 

 

$

3.71

 

 

 

4.20

 

 

$

-

 

Vested and expected to vest as of March 31, 2023

 

 

1,271

 

 

$

3.72

 

 

 

4.19

 

 

$

-

 

During the three and nine months ended March 31, 2023, the Company recognized total stock-based compensation expense associated with all restricted stock and stock options of $0.6 million and $2.0 million, respectively. During the three and nine months ended March 31, 2022, the Company recognized total stock-based compensation expense associated with all restricted stock and stock options of $0.5 million and $2.2 million, respectively.

As of March 31, 2023, the Company had unrecognized compensation costs related to all unvested restricted stock awards and stock options totaling $2.5 million.

During the nine months ended March 31, 2023, the Company issued compensation to certain employees in the form of GECC common shares to be settled with GECC shares currently held by the Company. The total value of GECC shares awarded for the nine months ended March 31, 2023 was $0.4 million, of which $0.1 million vested immediately, and the balance will vest annually pro-rata over a three year period. Related compensation expense was $0.1 million and $0.3 million for the three and nine months ended March 31, 2023, respectively.

During the three and nine months ended March 31, 2023, the Company issued compensation to certain employees in the form of restricted membership interest rights in MP II to be settled with the membership interest currently held by the Company. The total value of the MP II restricted membership interests awarded for the three and nine months ended March 31, 2023 was $0.1 million, which will vest on the third anniversary of the grant date. Related compensation expense was $11 thousand for the three and nine months ended March 31, 2023.

13. Income Taxes

As of June 30, 2022, the Company had net operating loss (NOL) and capital loss carryforwards for federal income tax purposes of approximately $821 million. Following the Sale of Controlling Interest in Forest, the Forest entity ceased being part of our consolidated tax group and NOL carryforwards attributed to Forest generally became unavailable for the Company's use going forward. The Company retained approximately $154 million of the federal carryforwards available to the Company as of June 30, 2022. Of these, approximately $139 million of federal NOL carryforwards will expire from 2023 through 2025 (including approximately $131 million that will expire on June 30, 2023). Federal NOL carryforwards generated in fiscal year 2018 or later of approximately $7 million can be carried forward indefinitely. Capital loss carryforwards of approximately $8 million can be carried forward through 2027.

26


In light of the Company’s history of cumulative operating losses, the Company recorded a valuation allowance for all of its federal and state deferred tax assets, as it is presently unable to conclude that it is more likely than not that the federal and state deferred tax assets in excess of deferred tax liabilities will be realized.

The Inflation Reduction Act (IRA) was enacted into law on August 16, 2022. Included in the IRA was a provision to implement a 15% corporate alternative minimum tax on "adjusted financial statement income" for applicable corporations and a 1% excise tax on repurchases of stock. These provisions are effective for tax years beginning after December 31, 2022. We are in the process of evaluating the provisions of the IRA, but we do not currently believe the IRA will have a material impact on our reported results, cash flows or financial position when it becomes effective.

14. Commitments and Contingencies

From time to time, the Company is involved in lawsuits, claims, investigations and proceedings that arise in the ordinary course of business. The Company maintains insurance to mitigate losses related to certain risks. The Company is not a named party in any other pending or threatened litigation that we expect to have a material adverse impact on our business, results of operations, financial condition or cash flows.

27


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Overview

GEG is a publicly-traded alternative asset management company focused on growing a scalable and diversified portfolio of long-duration, permanent capital vehicles across corporate credit, specialty finance, real estate and other asset classes. GEG and its subsidiaries currently manage Great Elm Capital Corp. (GECC), a publicly-traded business development company, and Monomoy Properties UpREIT, LLC (Monomoy UpREIT), an industrial-focused real estate investment trust, in addition to other investments. The combined assets under management of these entities at March 31, 2023 was approximately $630.7 million. The total level of our assets under management could be adversely affected by conditions outside of our control, including a decline in the market value of our assets under management, due to declines or heightened volatility in the capital markets, fluctuations in interest rates, the current inflationary environment, and other market factors, as well as financial crises, political or diplomatic developments in the U.S. or globally, including rising trade tensions between the U.S. and China, pandemics or other public health crises, such as a potential resurgence of COVID-19 or another similar highly infectious or contagious disease, trade wars, social or civil unrest, insurrection, war, including the ongoing conflict between Russia and Ukraine which has significantly impacted the global economy and financial markets, terrorism, natural disasters, or risks associated with global climate change.

We continue to explore other investment management opportunities, as well as opportunities in other areas that we believe provide attractive risk-adjusted returns on invested capital. As of the date of this report, we have not entered into any binding commitments to make additional acquisitions or investments in any of these areas.

On December 30, 2022, GEG and its wholly-owned subsidiary, Great Elm FM Acquisition, Inc. (FM Acquisition), entered into a stock purchase agreement (the Stock Purchase Agreement) with J.P. Morgan Broker-Dealer Holdings Inc. (JPM) to sell 61 shares of the common stock, $0.001 par value per share, of Forest Investments, Inc. (Forest) owned by FM Acquisition and GEG, which constitute 61% of the issued and outstanding shares of Forest’s common stock, to JPM for approximately $18.4 million in cash (the Sale of Controlling Interest in Forest).

In connection with the Stock Purchase Agreement, GEG, JPM and Forest entered into an amended and restated stockholders’ agreement (the Stockholders Agreement). Pursuant to the Stockholders Agreement, from January 17, 2023 until February 17, 2023, GEG had the right (the Put Option) to sell its remaining 19% interest in Forest (Investment in Forest) for its then fair market value. On January 17, 2023, the Company exercised the Put Option and sold the Investment in Forest for approximately $26.5 million in cash.

On January 3, 2023, GEG’s wholly-owned subsidiary, Great Elm DME Holdings, Inc., along with the minority owners of Great Elm Healthcare, LLC (HC LLC), entered into a purchase agreement with QHM Holdings, Inc., a subsidiary of Quipt Home Medical Corp (Quipt), to sell 100% of the outstanding membership interests in HC LLC to Quipt (the Sale of HC LLC) for $80.0 million, consisting of approximately $72.8 million in cash, $5.2 million of indebtedness assumed by Quipt and $2.0 million in shares of Quipt common stock based on the 20-day volume-weighted average price of Quipt’s common stock for the period ending on and including the second business day prior to the closing of the transaction. After transaction costs of $2.5 million, distributions to non-controlling interests of $5.9 million, and indemnity escrow payment of $0.4 million, cash proceeds to GEG and subsidiaries were $64.1 million. The disposal group satisfied the criteria for presentation as held for sale and discontinued operations through the date of sale, and as such our historical segment information was recast to reflect our ongoing business as a single reportable segment and to remove the activity of discontinued operations.

28


In January 2023, Monomoy BTS Corporation (MBTS) completed purchases of certain land parcels located in Canton, Mississippi, and Midway, Florida. Contemporaneously with the land purchases, MBTS entered into commercial lease agreements, as a lessor, in respect to the land parcels and build-to-suit improvements to be constructed thereon. The leases will commence upon substantial completion of the build-to-suit development, which is expected not later than the first calendar quarter of 2024. We intend to sell the land and improvements with the attached leases at or close to the respective lease commencement date. During the three and nine months ended March 31, 2023, the Company capitalized costs of $1.7 million within real estate under development (current) on its balance sheet, representing the cost of land and development and construction costs directly identifiable with the two real estate projects.

As of June 30, 2022, we had $821 million of net operating loss (NOL) and capital loss carryforwards for federal income tax purposes. Following the Sale of Controlling Interest in Forest, GEG retained approximately $154 million of these carryforwards, $131 million of which expire on June 30, 2023.

Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires our management to make significant estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These items are monitored and analyzed by our management for changes in facts and circumstances, and material changes in these estimates could occur in the future. During the three and nine months ended March 31, 2023 we did not make material changes in our critical accounting policies or underlying assumptions as disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 as it relates to recurring transactions.

Previously reported assets and liabilities related to our Durable Medical Equipment (DME) Business, primarily consisting of HC LLC and its subsidiaries, have been reclassified as assets and liabilities held for sale on the Company's consolidated balance sheet as of June 30, 2022. In addition, the historical results of the DME Business and related activity have been presented in the accompanying unaudited condensed consolidated statements of operations for the three and nine months ended March 31, 2023 and 2022 as discontinued operations. See Note 4 – Assets and Liabilities Held for Sale and Discontinued Operations to the accompanying unaudited condensed consolidated financial statements. Following presentation of our DME Business as discontinued operations, the Company views its operations and manages its business as one operating segment focused on growing a scalable and diversified portfolio of long-duration, permanent capital vehicles across corporate credit, specialty finance, real estate and other asset classes.

Results of Operations

The following table provides the results of our consolidated operations:

 

 

For the three months ended March 31,

 

 

For the nine months ended March 31,

 

(in thousands)

 

2023

 

 

Percent Change

 

2022

 

 

2023

 

 

Percent Change

 

2022

 

Revenue:

 

$

1,898

 

 

92%

 

$

988

 

 

$

5,637

 

 

88%

 

$

2,992

 

Operating costs and expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash compensation

 

 

(660

)

 

14%

 

 

(578

)

 

 

(2,246

)

 

(13)%

 

 

(2,572

)

Transaction costs

 

 

-

 

 

(100)%

 

 

(92

)

 

 

(425

)

 

(21)%

 

 

(535

)

Other selling, general and administrative

 

 

(3,826

)

 

50%

 

 

(2,546

)

 

 

(9,709

)

 

52%

 

 

(6,400

)

Depreciation and amortization

 

 

(281

)

 

NM

 

 

(89

)

 

 

(870

)

 

183%

 

 

(307

)

Total operating costs and expenses

 

 

(4,767

)

 

 

 

 

(3,305

)

 

 

(13,250

)

 

 

 

 

(9,814

)

Operating loss

 

 

(2,869

)

 

 

 

 

(2,317

)

 

 

(7,613

)

 

 

 

 

(6,822

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(1,095

)

 

(15)%

 

 

(1,286

)

 

 

(5,024

)

 

30%

 

 

(3,872

)

Other income (expense)

 

 

3,509

 

 

NM

 

 

(2,862

)

 

 

32,374

 

 

NM

 

 

(3,395

)

Total other income (expense), net

 

 

2,414

 

 

 

 

 

(4,148

)

 

 

27,350

 

 

 

 

 

(7,267

)

(Loss) income before income taxes from continuing operations

 

$

(455

)

 

 

 

$

(6,465

)

 

$

19,737

 

 

 

 

$

(14,089

)

 

29


Revenue

Revenues for the three and nine months ended March 31, 2023 increased $0.9 million and $2.6 million, respectively, as compared to the corresponding periods in the prior year. The increase is primarily attributable to the Monomoy UpREIT management agreement acquired in May 2022.

Operating Costs and Expenses

Operating costs and expenses for the three and nine months ended March 31, 2023 increased $1.5 million and $3.4 million, respectively, as compared to the corresponding periods in the prior year. This increase was mainly attributable to costs associated with servicing the recently acquired Monomoy UpREIT management agreement.

Other Expenses and Income

Interest expense for the three months ended March 31, 2023 decreased by $0.2 million, compared to the corresponding period in the prior year, as there was no interest expense related to the 35,010 shares of preferred stock issued by Forest to JPM on December 29, 2020 (the Forest Preferred Stock) after the Sale of Controlling Interest in Forest on December 30, 2022, which was partially offset by interest expense on the 7.25% notes due in 2027 issued in June 2022 (the GEGGL Notes) and on the $6.3 million promissory note issued to Imperial Capital Asset Management, LLC in May 2022 (the Seller Note) (fully repaid in February 2023). Interest expense for the nine months ended March 31, 2023 increased by $1.2 million, primarily due to interest on the GEGGL Notes and Seller Note, which was partially offset by decrease in interest expense on the Forest Preferred Stock following the Sale of Controlling Interest in Forest on December 30, 2022.

During the three months ended March 31, 2023, the Company recognized $3.5 million of other income (net), comprised of net realized and unrealized gain on investments of $2.0 million and dividends and interest income of $1.5 million. During the nine months ended March 31, 2023, the Company recognized $32.4 million of other income (net), comprised of gain on Sale of Controlling Interest in Forest of $10.5 million, unrealized gain on the Investment in Forest of $24.4 million recognized in December 2022, and dividends and interest income of $4.4 million, partially offset by net realized and unrealized loss on investments (excluding the Investment in Forest) of $6.9 million. During the three and nine months ended March 31, 2022, the Company recognized $2.9 million and $3.4 million of other expense (net), respectively, mainly attributed to net realized and unrealized loss on investments of $3.2 million and $5.1 million, respectively, and net realized and unrealized loss on investments of our consolidated fund, Great Elm SPAC Opportunity Fund, LLC (GESOF), of $0.3 million in both periods, partially offset by dividends and interest income of $0.6 million and $1.9 million, respectively.

Income Taxes

We do not expect that we will owe any federal taxes for the nine months ended March 31, 2023. As of June 30, 2022, the Company had net operating loss (NOL) and capital loss carryforwards for federal income tax purposes of approximately $821 million. Following the Sale of Controlling Interest in Forest, the Forest entity ceased being part of our consolidated tax group and NOL carryforwards attributed to Forest generally became unavailable for the Company's use going forward. The Company retained approximately $154 million of the federal carryforwards available to the Company as of June 30, 2022. Of these, approximately $139 million of federal NOL carryforwards will expire from 2023 through 2025 (including approximately $131 million that will expire on June 30, 2023). Federal NOL carryforwards generated in fiscal year 2018 or later of approximately $7 million can be carried forward indefinitely. Capital loss carryforwards of approximately $8 million can be carried forward through 2027. The Company assesses NOL and capital loss carryforwards based on taxable income on an annual basis.

30


Liquidity and Capital Resources

Cash Flows

Cash flows used in operating activities of our continuing operations for the nine months ended March 31, 2023 were $3.6 million. The adjustments to reconcile our net income from continuing operations of $19.7 million to net cash used in operating activities included add-backs for various non-cash charges, such as $2.0 million of stock-based compensation expense, $1.7 million of non-cash interest and amortization of capitalized issuance costs, and $0.9 million of depreciation and amortization, which was offset by deduction of $12.8 million of unrealized gain on our investments, $4.7 million of realized gain on our investments, $10.5 million of gain on Sale of Controlling Interest in Forest in December 2022, and the net negative change in our operating assets and liabilities of $2.0 million. During the nine months ended March 31, 2023 we also received $1.6 million attributed to sales of investments by GESOF. Cash flows provided by operating activities of our discontinued operations for the nine months ended March 31, 2023 were $0.8 million.

Cash flows provided by operating activities of our continuing operations for the nine months ended March 31, 2022 were $6.8 million. The net cash inflow was primarily the result of sales of investments by GESOF of $24.5 million, and non-cash adjustments of $2.2 million in stock-based compensation, $4.4 million in unrealized loss on investments, $0.7 million in realized loss on investments, $1.1 million of non-cash interest and amortization of capitalized issuance costs, $0.3 million related to depreciation and amortization, and $0.3 million of net realized and unrealized loss on investments of GESOF, partially offset by our net loss from continuing operations of $14.0 million, net negative change in our operating assets and liabilities of $0.7 million, and $11.7 million in purchases of investments by GESOF. The cash flows provided by operating activities of our discontinued operations for the nine months ended March 31, 2022 were $8.6 million.

Cash flows provided by investing activities of our continuing operations for the nine months ended March 31, 2023 were $41.1 million which is attributed to the combined proceeds from sale of Forest, net of cash sold, of $44.3 million, partially offset by purchases of investments of $3.1 million. Cash flows provided by investing activities of our discontinued operations for the nine months ended March 31, 2023 of $67.2 million were primarily attributed to the cash proceeds from the Sale of HC LLC, net of cash sold and before transaction costs and distributions to non-controlling interests, of $71.3 million, partially offset by other investing activities of our DME Business.

Cash flows provided by investing activities of our continuing operations for the nine months ended March 31, 2022 were $19 thousand and cash flows used in investing activities of our discontinued operations for the nine months ended March 31, 2022 were $4.5 million.

Cash flows used in financing activities of our continuing operations for the nine months ended March 31, 2023 were $42.4 million, which consisted of principal payments of $38.1 million on the promissory note issued to Forest on December 29, 2022 and fully repaid by January 3, 2023, and principal payments of $3.7 million on the Seller Note, as well as distributions to non-controlling interests in GESOF of $0.6 million. Cash flows used in financing activities of our discontinued operations for the nine months ended March 31, 2023 of $5.2 million were primarily attributed to distributions to non-controlling interests upon Sale of HC LLC of $5.9 million.

Cash flows used in financing activities of our continuing operations for the nine months ended March 31, 2022 were $13.2 million, primarily attributed to payments to the broker of GESOF of $12.3 million and distributions to non-controlling interests in GESOF of $0.9 million, while cash flows provided by financing activities of our discontinued operations for the same period were $0.7 million.

Financial Condition

As of March 31, 2023, we had an unrestricted cash balance of $84.1 million. We also held 1,569,787 shares of GECC common stock with an estimated fair value of $14.1 million as of March 31, 2023.

We believe we have sufficient liquidity available to meet our short-term and long-term obligations for at least the next 12 months.

31


Borrowings

As of March 31, 2023, the Company had $26.9 million in outstanding aggregate principal of the GEGGL Notes. The GEGGL Notes are due on June 30, 2027, and interest is paid quarterly. The GEGGL Notes include covenants that limit additional indebtedness or the payment of dividends in the event that our net consolidated debt to equity ratio is, or would be on a pro forma basis, greater than 2 to 1. In addition, if our net consolidated debt to equity ratio is greater than 2 to 1 at the end of any calendar quarter, we must retain no less than 10% of our excess cash flow as cash and cash equivalents until such time as our net consolidated debt to equity ratio is less than 2 to 1 at the end of a calendar quarter.

As of March 31, 2023, the Company had $37.0 million principal balance in convertible notes outstanding (including cumulative interest paid in-kind). The convertible notes are held by a consortium of investors, including related parties. The convertible notes accrue interest at 5.0% per annum, payable semiannually in arrears on June 30 and December 31, in cash or in kind at the option of the Company. The convertible notes are due on February 26, 2030, but are convertible at the option of the holders, subject to the terms therein, prior to maturity into shares of our common stock. Upon conversion of any note, the Company will pay or deliver, as the case may be, to the noteholder, in respect of each $1,000 principal amount of notes being converted, shares of common stock equal to the conversion rate in effect on the conversion date, together with cash, if applicable, in lieu of delivering any fractional share of common stock. To date, all interest on these instruments has been paid in-kind.

Recent Developments

On May 4, 2023, Peter A. Reed resigned as GEG’s Chief Executive Officer, effective immediately following the filing of GEG’s Form 10-Q for the fiscal quarter ended March 31, 2023. Following his resignation, Mr. Reed entered into a consulting agreement with GEG to provide transition services to the Company for a period of twelve months. On May 4, 2023, the Board appointed Jason Reese, the Executive Chairman of GEG’s Board of Directors since 2020, as Chairman and Chief Executive Officer of GEG, effective immediately following Mr. Reed’s resignation.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes in the market risks discussed in Item 7A. of our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.

Item 4. Controls and Procedures.

We evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2023. Disclosure controls and procedures include, without limitation, controls and procedures that are designed to ensure that the information we are required to disclose in reports that we file under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), to allow timely decisions regarding required disclosure. Our CEO and CFO participated in this evaluation and concluded that, as of March 31, 2023, our disclosure controls and procedures were effective.

There were no changes in our internal control over financial reporting for the quarter ended March 31, 2023, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

PART II—OTHER INFORMATION

No changes required to be disclosed.

32


Item 1A. Risk Factors.

We have disclosed the risk factors affecting our business, financial condition and operating results in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2022. There have been no material changes from the risk factors previously disclosed.

Item 6. Exhibits.

EXHIBIT INDEX

All references are to filings by Great Elm Group, Inc. (the registrant) with the SEC under File No. 001-39832.

Exhibit

Number Description

 

 

 

 

2.1

 

Purchase Agreement, dated January 3, 2023, among Great Elm Healthcare, LLC, Great Elm DME Holdings, Inc. and QHM Holdings Inc. (incorporated by reference to Exhibit 2.2 to the Form 8-K filed on January 3, 2023)

 

 

 

3.1

 

Certificate of Incorporation of Great Elm Group, Inc., dated October 23, 2020 (incorporated by reference to Exhibit 3.1 to the Form 8-K filed on December 29, 2020)

 

 

 

3.2

 

Amended and Restated Bylaws of Great Elm Group, Inc., dated November 14, 2022 (incorporated by reference to Exhibit 3.1 to the Form 8-K filed on November 14, 2022)

 

 

 

31.1*

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

31.2*

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

 

 

32.1*

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

101

 

Materials from the Great Elm Group, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in inline Extensible Business Reporting Language (XBRL): (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Stockholders’ Equity and Contingently Redeemable Non-Controlling Interest, (iv) Condensed Consolidated Statements of Cash Flows, and (v) related Notes to the Condensed Consolidated Financial Statements, tagged in detail (furnished herewith).

 

 

 

104

 

The cover page from the Great Elm Group, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in inline XBRL (included as Exhibit 101).

 

 

 

*Filed or furnished herewith.

33


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

GREAT ELM GROUP, INC.

 

 

Date: May 5, 2023

/s/ Peter A. Reed

 

Peter A. Reed

 

Chief Executive Officer

 

 

Date: May 5, 2023

/s/ Brent J. Pearson

 

Brent J. Pearson

 

Chief Financial Officer

 

 

34